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(57) ABSTRACT 
The bacterial plant pathogen Pseudomonas Syringae injects 
effector proteins into host cells via a type III protein secre 
tion system to cause disease. The invention relates to the 
discovery that the type III effector HopU1 is a mono-ADP 
ribosyltransferase (ADP-RT) and suppresses plant innate 
immunity. The HopU1 substrates in Arabidopsis thaliana 
extracts were RNA-binding proteins that possess RNA 
recognition motifs (RRMs). A. thaliana knock-out lines 
defective in the glycine-rich RNA-binding protein AtGRP7, 
a HopU1 substrate, were more susceptible than wild type 
plants to P syringae. The ADP-ribosylation of AtGRP7 by 
HopU1 required two arginines within the RRM. The inven 
tion provides novel methods for the modulation of the innate 
immune response of a plant to a biotic stress, including 
methods for enhancing or suppressing the innate immune 
6, 2006. response of the plant. 
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USES OF THE PSEUDOMONAS SYRINGAE 
EFFECTOR PROTEIN HOPU1 RELATED TO TS 
ABILITY TO ADP-RBOSYLATE EUKARYOTC 
RNA BINDING PROTEINS 
CROSS-REFERENCE TO RELATED 
APPLICATIONS 
0001. This application claims priority under 35 U.S.C. S 
119 of a provisional application Ser. No. 60/804,068 filed 
Jun. 6, 2006, which application is hereby incorporated by 
reference in its entirety. 
GRANT REFERENCE 
0002 This invention was made with government support 
under NSF Grant No. DBI-0077622, NSF Grant No. MCB 
0317165, and NIH Grant No. 1R56AIO69146-01. The Gov 
ernment has certain rights in the invention. 
FIELD OF THE INVENTION 
0003. The present invention provides methods for the 
production of plants with enhanced or Suppressed innate 
immune responses to a biotic stress. 
BACKGROUND OF THE INVENTION 
0004 Interactions between bacterial pathogens and their 
plant hosts generally fall into two categories: (1) compatible 
(pathogen-host), leading to intercellular bacterial growth, 
symptom development, and disease development in the host 
plant; and (2) incompatible (pathogen-nonhost), resulting in 
the hypersensitive response, a particular type of incompat 
ible interaction occurring, without progressive disease 
symptoms. During compatible interactions on host plants, 
bacterial populations increase dramatically and progressive 
symptoms occur. During incompatible interactions, bacterial 
populations do not increase, and progressive symptoms do 
not OCCur. 
0005. The hypersensitive response (“HR') is a rapid, 
localized necrosis that is associated with the active defense 
of plants against many pathogens (Horsfall et al., eds. Plant 
Disease: An Advanced Treatise Vol. 5, pp. 201 224, New 
York, N.Y.: Academic Press (1980); Mount et al., eds., 
Phytopathogenic Prokaryotes, Vol. 2, pp. 149 177, New 
York, N.Y.: Academic Press (1982)). The hypersensitive 
response elicited by bacteria is readily observed as a tissue 
collapse if high concentrations (~107 cells/ml) of a limited 
host-range pathogen like Pseudomonas Syringae or Erwinia 
amylovora are infiltrated into the leaves of nonhost plants 
(necrosis occurs only in isolated plant cells at lower levels 
of inoculum) (Klement, Nature 199:299-300 (1963); Kle 
ment et al., Phytopathology 54:474-477 (1963); Turner et 
al., Phytopathology 64:885-890 (1974); Mount et al., eds., 
Phytopathogenic Prokaryotes, Vol. 2., pp. 149-177, New 
York, N.Y.: Academic Press (1982)). The capacities to elicit 
the hyperSensitive response in a nonhost and be pathogenic 
in a host appear linked. As noted by Mount et al., eds., 
Phytopathogenic Prokaryotes, Vol. 2., pp. 149 177, New 
York, N.Y.: Academic Press (1982), these pathogens also 
cause physiologically similar, albeit delayed, necroses in 
their interactions with compatible hosts. Furthermore, the 
ability to produce the hypersensitive response or pathogen 
esis is dependent on a common set of genes, denoted hirp 
(Lindgren et al., J. Bacteriol. 168:512-22 (1986); Willis et 
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al., Mol. Plant-Microbe Interact. 4:132-138 (1991)). Conse 
quently, the hypersensitive response may hold clues to both 
the nature of plant defense and the basis for bacterial 
pathogenicity. 
0006 The hrp genes are widespread in gram-negative 
plant pathogens, where they are clustered, conserved, and in 
some cases interchangeable (Willis et al., Mol. Plant-Mi 
crobe Interact. 4:132-138 (1991); Dangl, ed., Current Topics 
in Microbiology and Immunology: Bacterial Pathogenesis 
of Plants and -Molecular and Cellular Mechanisms, pp. 
79-98, Berlin: Springer-Verlag (1994)). Several hrp genes 
encode components of a protein secretion pathway similar to 
one used by Yersinia, Shigella, and Salmonella spp. to 
secrete proteins essential in animal diseases (Van Gijsegem 
et al., Trends Microbiol. 1:175-180 (1993)). In E. amylo 
vora, P. syringae, and P Solanacearum, hrp genes have been 
shown to control the production and secretion protein elici 
tors of the hypersensitive response (He et al., Cell 73:1255 
1266 (1993); Wei et al., J. Bacteriol. 175:7958-7967 (1993); 
Arlat et al., EMBO J. 13:543-553 (1994)). Hypersensitive 
response elicitor proteins, designated harpins, are proteins 
found in phytopathogens containing a type III Secretion 
system and are typically glycine-rich, acidic, cysteine-lack 
ing, heat stable proteins (He et al., Cell 73: 1255-1266 
(1993). 
0007. The first of these proteins was discovered in E. 
amylovora Ea321, a bacterium that causes fire blight of 
rosaceous plants, and was designated harpin (Wei et al., 
Science 257:85-88 (1992)). Mutations in the encoding hrpN 
gene revealed that harpin is required for E. amylovora to 
elicit a hypersensitive response in nonhost tobacco leaves 
and incite disease symptoms in highly susceptible pear fruit. 
The P solanacearum GMI1000 Pop A1 protein has similar 
physical properties and also elicits the hypersensitive 
response in leaves of tobacco, which is not a host of that 
strain (Arlat et al., EMBO.J. 13:543-53 (1994)). However, P 
Solanacearum popA mutants still elicit the hypersensitive 
response in tobacco and incite disease in tomato. Thus, the 
role of these glycine-rich hypersensitive response elicitors 
can vary widely among gram-negative plant pathogens. 
0008. Other plant pathogenic hypersensitive response 
elicitors have been isolated, cloned, and sequenced from 
various organisms, including: HrpW from Erwinia amylo 
vora (Kim et al., J. Bacteriol. 180(19):5203-5210 (1998)); 
HrpN from Erwinia chrysanthemi (Bauer et al., MPMI 
8(4):484-91 (1995)); HrpN from Erwinia carotovora (Cuiet 
al., MPMI 9(7):565-73 (1996)); HrpN from Erwinia stew 
artii (Ahmad et al., 8th Intl. Cong. Molec. Plant-Microb. 
Inter. Jul. 14-19, 1996 and Ahmad et al., Ann. Mtg. Am. 
Phytopath. Soc. Jul. 27-31, 1996); hreX from Xanthomonas 
campestris (U.S. Patent Application Publ. No. 20020066122 
to Wei et al.); HrpZ from Pseudomonas Syringae pv. Syrin 
gae (He et al., Cell 73:1255-1266 (1993); WO 94/26782 to 
Cornell Research Foundation, Inc.); and HrpW from 
Pseudomonas Syringae pv. tomato (Charkowski et al., J. 
Bacteriol. 180:52.11-5217 (1998)). 
0009. Many gram-negative pathogens of plants and other 
eukaryotic-associated bacteria utilize type III protein secre 
tion systems (T3SSs). (He, S.Y., Nomura, K. & Whittam, T. 
S. Type III protein secretion mechanism in mammalian and 
plant pathogens. Biochim. Biophys. Acta 1694:181-206 
(2004); and Galan, J. E. & Wolf-Watz, H. Protein delivery 
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into eukaryotic cells by type III secretion machines. Nature 
444:567-573 (2006)). T3SSs are molecular syringes that 
inject bacterial proteins called effectors into eukaryotic host 
cells to modulate host physiology. In animal cells their 
activities alter specific host cell functions including phago 
cytosis, proinflammatory responses, apoptosis, and intracel 
lular trafficking (Mota, L. J. & Cornelis, G. R. The bacterial 
injection kit: type III secretion systems. Ann. Med. 37:234 
249 (2005)). Much less is understood about the activities and 
targets of type III effectors from plant pathogens. The 
emerging picture is that many type III effectors from plant 
pathogens Suppress host immune responses (Abramovitch, 
R. B., Anderson, J. C. & Martin, G. B. Bacterial elicitation 
and evasion of plant innate immunity. Nat. Rev. Mol. Cell. 
Biol. 7:601-611 (2006); Espinosa, A. & Alfano, J. R. Dis 
abling surveillance: bacterial type III secretion system effec 
tors that suppress innate immunity. Cell. Microbiol. 6:1027 
1040 (2004); and Mudgett, M. B. New insights to the 
function of phytopathogenic bacterial type III effectors in 
plants. Annu. Rev. Plant Biol. 56:509-531 (2005)). Thus far, 
effectors that possess cysteine protease, tyrosine phos 
phatase and E3 ubiquitin ligase activities have been impli 
cated in plant innate immunity Suppression (Axtell, M. J. & 
Staskawicz, B. J. Initiation of RPS2-specified disease resis 
tance in Arabidopsis is coupled to the AvrRpt2-directed 
elimination of RIN4. Cell 112:369-377 (2003); Mackey, D., 
Belkhadir, Y. Alonso, J. M., Ecker, J. R. & Dangl, J. L. 
Arabidopsis RIN4 is a target of the type III virulence effector 
AvrRpt2 and modulates RPS2-mediated resistance. Cell 
112:379-389 (2003); Shao, F. et al. Cleavage of Arabidopsis 
PBS1 by a bacterial type III effector. Science 301:1230-1233 
(2003); Lopez-Solanilla, E., Bronstein, P. A., Schneider, A. 
R. & Collmer, A. HopPtoN is a Pseudomonas Syringae Hrp 
(type III secretion system) cysteine protease effector that 
Suppresses pathogen-induced necrosis associated with both 
compatible and incompatible plant interactions. Mol. Micro 
biol. 54:353–365 (2004); Bretz, J. R. et al. A translocated 
protein tyrosine phosphatase of Pseudomonas Syringae pv. 
tomato DC3000 modulates plant defence response to infec 
tion. Mol. Microbiol. 49:389-400 (2003); Espinosa, A., Guo, 
M., Tam, V.C., Fu, Z. Q. & Alfano, J. R. The Pseudomonas 
syringae type III-Secreted protein HopPtol 2 possesses pro 
tein tyrosine phosphatase activity and Suppresses pro 
grammed cell death in plants. Mol. Microbiol. 49:377-387 
(2003); and Janjusevic, R., Abramovitch, R. B., Martin, G. 
B. & Stebbins, C. E. A bacterial inhibitor of host pro 
grammed cell death defenses is an E3 ubiquitin ligase. 
Science 311:222-226 (2006)), however, the enzymatic 
activities for most plant pathogen type III effectors that 
Suppress innate immunity remain unknown. 
BRIEF SUMMARY OF THE INVENTION 
0010. The present invention relates to a method of iden 
tifying a substrate of HopU1. In one aspect, the identifica 
tion is performed in vitro or in vivo. In one aspect, the 
substrate is identified from or in a plant or animal cell or 
extract. Also included are methods for enhancing the innate 
immune response of a plant. In one aspect, the method 
includes over-expressing a HopU1 Substrate in a plant cell. 
In another aspect, the method includes methods for Sup 
pressing the innate immune response of a plant. In one 
aspect, the method includes expressing HopU1 in a plant 
cell. 
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BRIEF DESCRIPTION OF THE DRAWINGS 
0011 FIG. 1. HopU1 is a putative mono-ADP-ribosyl 
transferase that contributes to virulence. (a) Alignment of the 
conserved regions of known mono-ADP-ribosyltransferases 
(ADP-RTs) with putative DC3000 ADP-RTS. Conserved 
residues are shown underlined and the invariant amino acids 
of the CT group of ADP-RTs (Sun, J. & Barbieri, J. T. 
Pseudomonas aeruginosa ExoT ADP-ribosylates CT 10 
regulator of kinase (Crk) proteins. J. Biol. Chem. 278, 
32794-32800 (2003)) are marked with asterisks. (b) hopU1 
(white box) is downstream of a type III-related promoter, the 
shcP type III chaperone gene, and the hopF2 effector gene 
(hatched boxes). (c) RNA was isolated from DC3000 (WT) 
or the AhopU1 mutant grown in either rich media (1) or a 
minimal medium that induces type III-related genes (2) and 
used in RT-PCR reactions. A DNA control (C) and no RT 
controls (No RT) were included. 
0012 FIG. 2. HopU1 suppresses outputs of plant innate 
immunity. (a) DC3000, AhopU1 mutant, and the AhopU1 
mutant expressing hopU1 were infiltrated into tobacco 
leaves at threshold cell densities (1x10° cells/ml). After 24 
h the tissue was assessed for HR production. (b) The 
AhopU1 mutant carrying a vector control (pVector), a hopU1 
construct (phopU1), or a hopU1 ADP-RT catalytic mutant 
construct (phopU1) were infiltrated into tobacco at 1x107 
cells/ml and assessed for HR production after 24 h. (c) 
Callose deposition was visualized in A. thaliana plants 
expressing HopU1-HA or the HopU1-HA mutant 16 h 
after treatment with flg22. (d) Callose deposition was quan 
tified by counting the number of callose foci per field of 
view. Twenty leaf regions (4 fields of view from 5 different 
leaves) were averaged and error bars (S.e.m.) are indicated. 
The experiment was repeated three times. 
0013 FIG. 3. HopU1-His ADP-ribosylates poly-L-argi 
nine and proteins in Arabidopsis and tobacco. (a) SDS 
PAGE of partially purified HopU1-His and HopU1-His 
catalytic mutant (HopU1-His) used in ADP-RT assays. 
(b) HopU1-His (stippled bar), HopU1-His (white bar), 
and a BSA control (black bar) were incubated with poly-L- 
arginine in the presence of PI-NAD. :P-labeled products 
were quantified with liquid scintillation. The specific activ 
ity unit is umole 'P transferred/min/umole of HopU1 times 
10'. The experiment was performed twice and the stan 
dard errors are indicated. (c) Autoradiograms of ADP-RT 
assays with either Arabidopsis (At) or tobacco (Nt) extracts 
with HopU1-His or HopU1-His. 
0014 FIG. 4. HopU1-His ADP-ribosylates recombinant 
RNA-binding proteins in vitro and in planta. (a) Recombi 
nant CP-RBP and GR-RBP glutathione S-transferase (GST) 
fusions and a GST control were used in ADP-RT assays with 
HopU1-His. ADP-RT reactions were subjected to SDS 
PAGE followed by autoradiography. The substrate fusions 
are listed with their A. thaliana locus or protein name. (b) 
Schematic representation of the RRM and glycine-rich 
domains within AtGRP7 and the locations of the arginine 
residues (R) throughout the protein. Black and grey sections 
within the RRM domain depict RNP1 and RNP2, respec 
tively, two conserved regions within RRM domain (Burd, C. 
G. & Dreyfuss, G. Conserved structures and diversity of 
functions of RNA-binding proteins. Science 265, 615-621 
(1994)). The locations of the arginine residues (R) are 
indicated. (c) In vitro ADP-RT assays were done with 
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HopU1-His and various AtGRP7-GST fusions. These 
included an RRM-GST fusion, a glycine-rich domain-GST 
fusion, and AtGRP7-GST mutants that have each arginine 
within the RRM domain separately substituted with lysine. 
Autoradiograms (top panel) indicate the AtGRP7-GST 
derivatives that maintained the ability to be ADP-ribosylated 
and immunoblots (bottom panel) indicate the relative sta 
bility of each AtGRP7-GST derivative. (d) AtGRP7 fused to 
an HA epitope (AtGRP7-HA) or an AtGRP7-HA derivative 
that is unable to be ADP-ribosylated (AtGRP7Raz-HA) 
were transiently expressed in N. benthamiana with HopU1 
FLAG or the ADP-RT catalytic mutant HopU1-FLAG. 
After 40 h leaf samples were subjected immunoblot analysis 
using anti-HA and anti-FLAG antibodies. (a,c) Molecular 
mass markers (kDa) are indicated. 
0.015 FIG. 5. Analyses of A. thaliana Atgrp7-1 mutant 
plants Suggest AtGRP7 plays a role in innate immunity. (a) 
Disease symptoms in Atgrp7-1 plants and A. thaliana Col-0 
plants after spray-inoculation with at a cell density of 2x10 
cells/ml. Pictures were taken after 5 days. The experiments 
in b and ‘c’ were repeated five times with similar results. 
(b) Bacterial growth assays of wild type DC3000 and the 
AhrcC mutant spray-inoculated at a cell density of 2x10 
cells/ml onto Atgrp7-1 and wild type A. thaliana Col-0 
plants. (c) Callose deposition was determined in A. thaliana 
Col-0 and Atgrp7-1 mutant plants 16 h after treatment with 
flg22. The number of callose foci per field of view for 20 leaf 
regions (4 fields of view from 5 different leaves) were 
averaged ts.e.m. The experiment was repeated three times 
with similar results. 
0016 FIG. 6. HopU1 is injected by the DC3000 T3SS 
and contributes to virulence. (a) Adenylate cyclase (CyaA) 
assays were carried out by infiltrating DC3000 and a AhrcC 
mutant (defective in T3SS) carrying constructs that pro 
duced HopU1-CyaA, HopU1-CyaA (HopU1 catalytic 
mutant), or AvrPtol-Cya (a type III effector known to be 
injected), respectively, into Nicotiana benthamiana. cAMP 
levels were determined 10 h after infiltration. (b) Bacterial 
strains were inoculated into A. thaliana Col-0 leaves by 
dipping plants into bacterial Suspensions. 
0017 FIG. 7. Ion leakage conductivity assays to quantify 
cell death in the presence of HopU1. (a) DC3000, the 
AhopU1 mutant, the AhopU1 mutant expressing hopU1 in 
trans (phopU1) were infiltrated into tobacco leaves at thresh 
old cell densities and after 24 h conductivity assays were 
performed on leaf tissue. The AhopU1 mutant infiltrated leaf 
tissue had greater conductivity than leaf tissue infiltrated 
with wild type DC3000 consistent with HopU1 acting as an 
HR suppressor. (b) The DC3000 AhopU1 mutant carrying 
either a vector control (vector), a hopU1 construct 
(phopU1), or a hopU1 ADP-RT catalytic mutant construct 
(phopU1) were infiltrated into Nicotiana tabacum 
(tobacco) at threshold cell densities. Conductivity assays 
were carried out after 24 h. When HopU1 was expressed 
the conductivity was similar to the DC3000 AhopU1 mutant 
indicating the HR suppression ability of HopU1 required a 
functional ADP-RT catalytic site. 
0018 FIG. 8. HopU1-expressing Arabidopsis plants 
elicit a delayed atypical AvrRpt2-dependent HR. A. thaliana 
Col-O plants expressing either HopU1-HA or HopU1-HA 
were infiltrated with DC3000 with or without the type III 
effector gene avrRpt2. After 20 h plants were assessed for 
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production of an HR. An HR typically develops in HopU1 
HA plants at about 25 h. approximately 10 h longer than it 
takes to develop in wild type plants. 
0.019 FIG. 9. Representative examples of identification 
of protein spots that migrated similarly to ADP-RT activity 
spots. (a) An Arabidopsis soluble protein extract was incu 
bated with HopU1-His in the presence of 'P-NAD. The 
reaction mix was subjected to two-dimensional SDS-PAGE 
and stained with Coomassie blue (top panel). The dried 
polyacrylamide gel was exposed to autoradiography film 
(bottom panel). The black arrowhead in the top panel 
identifies a protein that possessed the same migration as an 
ADP-ribosylated activity spot in the bottom panel (black 
arrowhead). (b) As described in the Methods, a crude A. 
thaliana Col-0 extract was separated on a HighTrap Q anion 
exchange column and fractions were examined for proteins 
that were ADP-ribosylated by HopU1-His. ADP-ribosyl 
transferase assays were carried out on all fractions, the 
reaction mixtures were subjected to SDS-PAGE, and auto 
radiography. Autoradiograms from the fractions that con 
tained the majority of HopU1-His substrates based on a high 
level of 'P incorporation are shown. (c., d) A. thaliana 
extract fractions after ion exchange chromatography were 
used in ADP-ribosyltransferase assays and subjected to 
two-dimensional SDS-PAGE. Shown are representative gels 
(top panel in both c- and d) stained with Coomassie blue and 
an autoradiogram (lower panel in both c-d) containing 
aliquots from fraction 42 (panel c) or 23 (panel d). The black 
arrowheads present in the top panels identify protein spots 
that migrated similarly with protein spots that were modified 
by HopU1 His in the lower panel. Molecular weight markers 
in kilodaltons are indicated on the left (a-d). 
0020 FIG. 10. Localization of HopU1-GUS, HopU1 
GFP, and substrate GFP fusions in plant cells. (a) Biolistic 
transformation of onion epidermal cells was performed with 
Agrobacterium binary constructs carrying either the uidA 
gene encoding B-glucuronidase (GUS) or the uidA gene 
fused to HopU1 (HopU1-GUS). After 24 h the plant tissue 
was histochemically stained for GUS activity and photo 
graphed. (b-d) hopU1-GFP DNA, DNA encoding HopU1 
substrate GFP fusions, or GFP encoding DNA was tran 
siently delivered into N. benthamiana leaves with Agrobac 
terium-mediated delivery. After 40 h, the leaf tissue was 
viewed with confocal microscopy using single excitation 
(488 nm) and dual-emission filters (522 nm for GFP and 680 
nm for chloroplast autofluorescence). (b) HopU1-GFP or 
GFP control merged images are shown. (c) GR-RBP-GFP 
fusions are shown. (d) Chloroplast RNA-binding proteins 
encoded by the A. thaliana loci At2g37220. 1, AtSg50250.1. 
and Atag24770.1 fused to GFP were visualized for GFP (top 
panel), and for chloroplast autofluorescence (middle panel). 
GFP and autofluorescence images were merged in the bot 
tom panel. 
0021 FIG. 11. Characterization of a SALK T-DNA 
knock-out line designated Atgrp7-1 defective in the AtGRP7 
gene. (a) Schematic representation of the AtGRP7 locus in 
A. thaliana Col-0 in relation to the T-DNA insertion in 
SALK line SALK 039556.21.25.X. Black boxes depict the 
two exons (E1 and E2) of AtGRP7; the primers used to 
confirm the homozygosity of the Atgrp7-1 mutant (listed in 
Table 3 as P2012, P1947, and P2013) are depicted here as 
P1, P2, and P3: the T-DNA insertion is represented as a 
triangle. (b) PCR with primer set P1/P3, which was used to 
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amplify wild type Col-0 DNA, and primer set P1/P2, which 
was used to amplify a junction band containing both A. 
thaliana DNA and T-DNA confirmed that the Atgrp7-1 
mutant is homozygous for the T-DNA insert. (c) Reverse 
transcriptase (RT)-PCR with primers (P1932 and P1929 in 
Table 3) that anneal to the full length coding sequence 
showing that AtGRP7 mRNA was not detectable in the 
Atgrp7-1 mutant line. RT-PCR reactions contained RNA 
from wild type Col-O plants or the Atgrp7-1 mutant; inclu 
sion or exclusion of RT in the reactions is indicated by a + 
or '-'. (d) Immunoblot analysis (left panel) of soluble 
proteins from leaves of A. thaliana Col-0 and Atgrp7-1 
mutant plants using anti-GRP antibodies, which recognizes 
AtGRP7. HopU1-His ADP-RT assays were performed with 
the same samples. The autoradiogram (right panel) shows 
the absence of an ADP-RT high-affinity band in the Atgrp7-1 
lane (indicated with an arrow). 
0022 FIG. 12. Characterization of a SALK T-DNA 
knock-out line designated Atgrp7-2 defective in the AtGRP7 
gene. (a) Schematic representation of the AtGRP7 locus in 
A. thaliana Col-0 in relation to the T-DNA insertion in 
SALK line SALK 051743.42.85.X. Black boxes depict the 
two exons (E1 and E2) of AtGRP7; the primers used to 
confirm the homozygosity of the Atgrp7-2 mutant (listed in 
Table 3 as P2456, P1947, and P2457) are depicted here as 
P4, P2, and P5; the T-DNA insertion is represented as a 
triangle. (b) PCR with primer set P4/P5, which was used to 
amplify wild type Col-0 DNA, and primer set P2/P5, which 
was used to amplify a junction band containing both A. 
thaliana DNA and T-DNA confirmed that the Atgrp7-2 
mutant is homozygous for the T-DNA insert. The junction 
band was sequenced and the T-DNA insert was found to be 
within the coding region of AtGRP7 in the first exon. This 
is a different location than indicated on the SIGnAL website 
(http://signal. salk.edu/). (c) Reverse transcriptase (RT)-PCR 
with primers (P1932 and P1929 in Table 3) that anneal to the 
full length coding sequence showing that AtGRP7 mRNA 
was not detectable in the Atgrp7-2 mutant line. RT-PCR 
reactions contained RNA from wild type Col-O plants or the 
Atgrp7-2 mutant. (d) Immunoblot analysis of soluble pro 
teins from leaves of A. thaliana Col-0 and Atgrp7-2 mutant 
plants using anti-GRP antibodies, which recognizes 
AtGRP7. (e) Bacterial growth assays with wild type P. s. 
tomato DC3000 and the AhrcC mutant on wild type A. 
thaliana Col-O plants compared to Atgrp7-2 mutant plants. 
(f) Disease symptoms on wild type A. thaliana Col-0 and 
Atgrp7-2 plants infected with DC3000. Pictures were taken 
5 days after spray-inoculation. (g) Callose deposition in A. 
thaliana Col-0 and Atgrp7-2 mutant plants 16 h after treat 
ment with flg22. The number of callose foci perfield of view 
for 20 leaf regions (4 fields of view from 5 different leaves) 
were averaged and the standard errors are indicated as error 
bars. 
0023 FIG. 13. Proposed model of suppression of plant 
innate immunity by the HopU1 ADP-RT type III effector. P. 
syringae pv. tomato DC3000 injects HopU1 and other type 
III effectors into plant cells via its type III secretion system. 
Innate immunity can be triggered by a type III effector 
(depicted above as the A-labelled diamond) if it is recog 
nized directly or indirectly by a resistance (R) protein or by 
a PAMP perceived by PAMP receptors (e.g., FLS2). Acti 
vated type III effector- and PAMP-triggered signal transduc 
tion pathways result in transcriptional changes in the plant 
that favor plant resistance to the pathogen. Our model 
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predicts that in the absence of HopU1 (U 1) (as in 1), innate 
immunity-induced mRNAs are stabilized, transported, or 
processed by RNA-binding proteins (RBPs) in the nucleus 
or the cytoplasm (as shown) resulting in the production of 
immunity-related products that facilitate the outputs of 
innate immunity, including the deposition of callose and the 
HR. In the presence of HopU1 (as in 2), one or several RBPs 
are ADP-ribosylated by HopU1 altering their normal func 
tion and, subsequently, affecting RNA metabolism. For 
example, the ADP-ribose modification may prevent a RBP 
from binding mRNA as depicted. This results in a Sup 
pressed innate immune response favoring the Survival of the 
pathogen. cw, cell wall; pm, plasma membrane; nm, nuclear 
membrane. 
0024 FIG. 14. HopU1-His ADP-ribosylates at least one 
protein in human cancer cell extracts. ADP-RT reactions (using P-NAD) were carried out with 34 ug extracts of 
22Rv1 human cancer cells and 200 ng of HopU1-His or 
HopU1-His. Each reaction was separated with SDS 
PAGE and exposed to X-ray film for 10 m. 
DETAILED DESCRIPTION OF THE 
PREFERRED EMBODIMENT 
0025. Unless defined otherwise, all technical and scien 
tific terms used herein have the same meaning as commonly 
understood by one of ordinary skill in the art to which this 
invention belongs. Unless mentioned otherwise, the tech 
niques employed or contemplated herein are standard meth 
odologies well known to one of ordinary skill in the art. The 
materials, methods and examples are illustrative only and 
not limiting. The following is presented by way of illustra 
tion and is not intended to limit the scope of the invention. 
0026. The present inventions now will be described more 
fully hereinafter with reference to the accompanying draw 
ings, in which some, but not all embodiments of the inven 
tion are shown. Indeed, these inventions may be embodied 
in many different forms and should not be construed as 
limited to the embodiments set forth herein; rather, these 
embodiments are provided so that this disclosure will satisfy 
applicable legal requirements. Like numbers refer to like 
elements throughout. 
0027 Many modifications and other embodiments of the 
inventions set forth herein will come to mind to one skilled 
in the art to which these inventions pertain having the benefit 
of the teachings presented in the foregoing descriptions and 
the associated drawings. Therefore, it is to be understood 
that the inventions are not to be limited to the specific 
embodiments disclosed and that modifications and other 
embodiments are intended to be included within the scope of 
the appended claims. Although specific terms are employed 
herein, they are used in a generic and descriptive sense only 
and not for purposes of limitation. 
Overview 
0028. The present invention relates to the discovery that 
a Hrp-dependent outer protein (Hop) HopU1 is an adenosine 
diphosphate ribosyltransferase (ADP-RT) that acts as a 
Suppressor of the innate immune responses of a plant, for 
example in Nicotiana tabacum cv. Xanthi (tobacco) or 
Arabidopsis thaliana, exposed to a biotic stress. In vitro 
studies identified five RNA Binding Protein (RBP) plant 
proteins that are ADP-ribosylated by HopU1. Without wish 
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ing to be bound by this theory, it is believed that expressing 
HopU1 in a plant Suppresses innate immunity in a manner 
related to HopU1’s ability to ADP-ribosylate a substrate, 
thereby interfering with the substrate's ability to bind RNA 
and consequently quelling the hosts immunity by affecting 
RNA metabolism and the defense transcriptome. 
0029 Modulation of the expression level and activity of 
HopU1 and its substrates in a plant would provide a mecha 
nism for manipulating the plants innate immune response. 
Accordingly, the present invention provides methods for the 
production of plants with enhanced or Suppressed innate 
immune responses, for example, to a biotic stress, Such as a 
pathogen. In one aspect, the methods include introducing 
into a plant or an animal cell, tissue, or plant one or more 
polynucleotides encoding HopU1 polypeptides having the 
enzymatic activity of ADP-RT. This may be accomplished 
by introducing HopU1 polynucleotides into the plant nuclear 
and/or plant plastidial genome. 
0030. In one aspect, the methods include introducing into 
a plant or animal cell, tissue, plant one or more polynucle 
otides encoding HopU1 Substrate polypeptides capable of 
being ADP-ribosylated by HopU1. This may be accom 
plished by introducing the HopU1 substrate polynucleotide 
into the plant nuclear and/or plant plastidial genome. 
0031 Plants expressing HopU1 will provide suppressed 
innate immune response to a biotic stress. Additionally, they 
serve as a system in which to determine the role of targets 
of HopU1 and other components in a plants innate immune 
response. Advantageously, plants over-expressing a HopU1 
Substrate will provide an enhanced innate immune response 
to the biotic stress. 
0032. The practice of the present invention will employ, 
unless otherwise indicated, conventional techniques of 
botany, microbiology, tissue culture, molecular biology, 
chemistry, biochemistry and recombinant DNA technology, 
which are within the skill of the art. Such techniques are 
explained fully in the literature. See, e.g., Langenheim and 
Thimann, (1982) Botany: Plant Biology and Its Relation to 
Human Affairs, John Wiley; Cell Culture and Somatic Cell 
Genetics of Plants, vol. 1, Vasil, ed. (1984); Stanier, et al., (1986) The Microbial World, 5" ed., Prentice-Hall; Dhringra 
and Sinclair, (1985) Basic Plant Pathology Methods, CRC 
Press; Maniatis, et al., (1982) Molecular Cloning: A Labo 
ratory Manual DNA Cloning, vols. I and II, Glover, ed. 
(1985); Oligonucleotide Synthesis, Gait, ed. (1984); Nucleic 
Acid Hybridization, Hames and Higgins, eds. (1984); and 
the series Methods in Enzymology, Colowick and Kaplan, 
eds, Academic Press, Inc., San Diego, Calif. 
0033 Units, prefixes, and symbols may be denoted in 
their SI accepted form. Unless otherwise indicated, nucleic 
acids are written left to right in 5' to 3' orientation; amino 
acid sequences are written left to right in amino to carboxy 
orientation, respectively. Numeric ranges are inclusive of the 
numbers defining the range. Amino acids may be referred to 
herein by either their commonly known three letter symbols 
or by the one-letter symbols recommended by the IUPAC 
IUB Biochemical Nomenclature Commission. Nucleotides, 
likewise, may be referred to by their commonly accepted 
single-letter codes. The terms defined below are more fully 
defined by reference to the specification as a whole. 
0034. As used herein, "polynucleotide' includes refer 
ence to a deoxyribopolynucleotide, ribopolynucleotide, or 
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analogs thereof that have the essential nature of a natural 
ribonucleotide in that they hybridize, under stringent hybrid 
ization conditions, to Substantially the same nucleotide 
sequence as naturally occurring nucleotides and/or allow 
translation into the same amino acid(s) as the naturally 
occurring nucleotide(s). A polynucleotide can be full-length 
or a Subsequence of a native or heterologous structural or 
regulatory gene. Unless otherwise indicated, the term 
includes reference to the specified sequence as well as the 
complementary sequence thereof. Thus, DNAS or RNAs 
with backbones modified for stability or for other reasons 
are “polynucleotides’ as that term is intended herein. More 
over, DNAS or RNAS comprising unusual bases, such as 
inosine, or modified bases, such as tritylated bases, to name just two examples, are polynucleotides as the term is used 
herein. It will be appreciated that a great variety of modi 
fications have been made to DNA and RNA that serve many 
useful purposes known to those of skill in the art. The term 
polynucleotide as it is employed herein embraces Such 
chemically, enzymatically or metabolically modified forms 
of polynucleotides, as well as the chemical forms of DNA 
and RNA characteristic of viruses and cells, including inter 
alia, simple and complex cells. 
0035) Suitable plants for use in methods of the present 
invention include but are not limited to, an almond, apple, 
apricot, Arabidopsis, artichoke, atriplex, avocado, barley, 
beet, birch, brassica, cabbage, cacao, cantaloupe, carna 
tions, castorbean, cauliflower, celery, clover, coffee, corn, 
cotton, cucumber, garlic, grape, grapefruit, hemp, hops, 
lettuce, maple, melon, mustard, oak, oat, olive, onion, 
orange, pea, peach, pear, pepper, pine, plum, poplar, potato, 
prune, radish, rape, rice, roses, rye, Salicornia, Sorghum, 
Soybean, spinach, squash, Strawberries, Sunflower, Sweet 
corn, tobacco, tomato or wheat plant. In another aspect, the 
term animal includes, but is not limited to, a mouse, cow, 
pig, dog, cat, monkey or human. 
0036) As used herein, the term “plant includes reference 
to an immature or mature whole plant, including a plant that 
has been detasseled or from which seed or grain has been 
removed. Seed or embryo that will produce the plant is also 
considered to be the plant. 
0037. The terms “polypeptide,”“peptide,” and “protein' 
are used interchangeably herein to refer to a polymer of 
amino acid residues. The terms apply to amino acid poly 
mers in which one or more amino acid residue is an artificial 
chemical analogue of a corresponding naturally occurring 
amino acid, as well as to naturally occurring amino acid 
polymers. 
0038. As used interchangeably herein, a “HopU1 activ 
ity”, “biological activity of HopU1 or “functional activity 
of HopU1”, refers to an activity exerted by a HopU1 protein, 
polypeptide or portion thereofas determined in Vivo, or in 
vitro, according to standard techniques. For example, 
HopU1 activity includes ADP-ribosylating a substrate in 
vitro or in Vivo, or acting to Suppress the innate immune 
response of a plant as provided by the present invention. 
0039. As used herein, the term HopU1 includes but is not 
limited to the sequence of Pseudomonas Syringae pv. tomato 
str. DC3000 disclosed in GenBank accession no. 
AAO54045.1 GI:28850966 (protein) and AE016853 (nucle 
otide). (Buell, Ret al. The complete genome sequence of the 
Arabidopsis and tomato pathogen Pseudomonas syringae 
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pv. tomato DC3000, Proc. Natl. Acad. Sci. U.S.A. 
100(18): 10181-10186 (2003), and also includes conserva 
tively modified variants, regardless of source and any other 
variants which retain the biological properties of the HopU1, 
for example, HopU1 activity. The term “HopU1 polypep 
tide' refers to one or more amino acid sequences. The term 
is also inclusive of fragments, variants, homologs, alleles or 
precursors (e.g., preproproteins or proproteins) thereof. A 
“HopU1 protein’ comprises a HopU1 polypeptide. Unless 
otherwise stated, the term “HopU1 nucleic acid means a 
nucleic acid comprising a polynucleotide (“HopU1 poly 
nucleotide') encoding a HopU1 polypeptide. 
0040. The term “HopU1 substrate” as used herein refers 
to a molecule ADP-ribosylated by a HopU1 protein or 
polypeptide. The term “HopU1 substrate polypeptide' refers 
to one or more amino acid sequences. The term is also 
inclusive of fragments, variants, homologs, alleles or pre 
cursors (e.g., preproproteins or proproteins) thereof. A 
“HopU1 substrate protein’ comprises a HopU1 substrate 
polypeptide. Unless otherwise stated, the term “HopU1 
Substrate nucleic acid means a nucleic acid comprising a 
polynucleotide (“HopU1 substrate polynucleotide') encod 
ing a HopU1 Substrate polypeptide. Exemplary Substrates 
include RBPs, such as GR-RBPs and CP-RBPs. HopU1 
Substrate polypeptides that are targets of HopU1 Suppress 
the innate immune response of a plant when ADP-ribosy 
lated by HopU1 or enhance the innate immune system when 
over-expressed in a plant cell or plant. It is also contem 
plated that certain residues of the HopU1 substrate may be 
altered to prevent ADP-ribosylation by HopU1. 
0041. The term "suppressing the innate immune 
response' as used herein includes making a plants immune 
system more Susceptible to a biotic stress for example, 
pathogens. Such as bacteria, fungi or viruses, including 
microbial invasions. Suppressing the innate immune 
response includes decreasing the plants innate immune 
response, for example, so that the HR of the plant is 
decreased or inhibited upon exposure to a biotic stress. The 
Suppression of the innate immune response of a Subject plant 
can be determined using a variety of in vitro or in vivo 
measurements of innate immune responses to a biotic stress, 
for example, including the levels of reactive oxygenation 
species (ROS) and nitric oxide (NO), changes in cytoplas 
mic Ca2+ levels, production of pathogen-related (PR) gene 
expression, phytoalexin production, papillae formation (i.e 
thickening of the cell wall), and callose (P-1-3 glucan 
deposition) in the cell wall. (Dangl, J. L., and J. D. Jones. 
Plant pathogens and integrated defence responses to infec 
tion. Nature 411:826-833 (2001); Gomez-Gomez, L., and T. 
Boller. Flagellin perception: a paradigm for innate immu 
nity. Trends Plant Sci. 7:251-256 (2002); Heath, M. C. 
Nonhost resistance and nonspecific plant defenses. Curr. 
Opin. Plant Biol. 0.3:315-319 (2000); and Jones, D. A., and 
D. Takemoto. Plant innate immunity—direct and indirect 
recognition of general and specific pathogen-associated 
molecules. Curr. Opin. Immunol. 16:48-62 (2004)), or the 
hypersensitive response, present in the plant. (Goodman, R. 
N., and A. J. Novacky. The hypersensitive reaction of plants 
to pathogens: A resistance phenomenon. APS Press, St. Paul 
(1994); and Heath, M. C. Hypersensitive response-related 
death. Plant Mol. Biol. 44:321-33 (2000)). 
0042. The term "enhancing the innate immune response' 
as used herein includes making a plant's immune system 
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more resistant to a biotic stress for example, pathogens. Such 
as bacteria, fungus or viruses, including microbial invasions. 
Enhancing the innate immune response includes increasing 
the plants innate immune response, for example, so that the 
HR of the plant is increased or maintained upon exposure to 
a biotic stress. The enhancement of the innate immune 
response of a Subject plant can be determined using a variety 
of in vitro or in vivo measurements of innate immune 
responses to a biotic stress, for example, including the levels 
of reactive oxygenation species (ROS) and nitric oxide 
(NO), changes in cytoplasmic Ca2+ levels, production of 
pathogen-related (PR) gene expression, phytoalexin produc 
tion, papillae formation (i.e. thickening of the cell wall), and 
callose (B-1-3 glucan deposition) in the cell wall. (Dangl, J. 
L., and J. D. Jones. Plant pathogens and integrated defence 
responses to infection. Nature 411:826-833 (2001); Gomez 
Gomez, L., and T. Boller. Flagellin perception: a paradigm 
for innate immunity. Trends Plant Sci. 7:251-256 (2002); 
Heath, M. C. Nonhost resistance and nonspecific plant 
defenses. Curr. Opin. Plant Biol. 0.3:315-319 (2000); and 
Jones, D. A., and D. Takemoto. Plant innate immunity— 
direct and indirect recognition of general and specific patho 
gen-associated molecules. Curr. Opin. Immunol. 16:48-62 
(2004)), or the hypersensitive response, present in the plant. 
(Goodman, R. N., and A. J. Novacky. The hypersensitive 
reaction of plants to pathogens: A resistance phenomenon. 
APS Press, St. Paul (1994); and Heath, M. C. Hypersensitive 
response-related death. Plant Mol. Biol. 44:321-33 (2000)). 
0043. The term "hypersensitive response (HR) refers to 
a rapid, defense-associated programmed death of plant cells 
in contact with the pathogen (Alfano & Collmer, J. Bacte 
riol. 179:5655-5662 (1997)). 
0044) The term “innate immune response' includes any 
response of the immune system including both non-specific 
and specific responses. 
0045 ADP-ribosylation, as used herein, is a chemical or 
biochemical reaction involving the addition of ADP to a 
substrate, to form a ribosylated substrate or product. 
0046. As used herein, the term “biotic stress' refers to 
any pathogen, such as a bacteria, fungi, protozoa and viruses 
or any biological organism that is harmful to plants and 
includes, an organism oran infectious agent whose infection 
around or inside the cells of viable plant tissue elicits a 
disease response. Other examples of biotic stresses include 
those injuries resulting from infections by insects, nema 
todes, Snails, mites, weeds, and physical damage caused by 
people (i.e. grazing, tredding, etc.). 
0047 A “subject plant or plant cell' is one in which 
genetic alteration, such as transformation, has been effected 
as to a gene of interest, or is a plant or plant cell which is 
descended from a plant cell so altered and which comprises 
the alteration. A “control or “control plant’ or “control 
plant cell provides a reference point for measuring changes 
in phenotype of the Subject plant or plant cell. 
0048. A control plant or plant cell may comprise, for 
example: (a) a wild-type plant or cell, i.e., of the same 
genotype as the starting material for the genetic alteration 
which resulted in the subject plant or cell; (b) a plant cell of 
the same genotype as the starting material but which has 
been transformed with a null construct (i.e. with a construct 
which has no known effect on the trait of interest, such as a 
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construct comprising a marker gene); (c) a plant or plant cell 
which is a non-transformed segregant among progeny of a 
Subject plant or plant cell; (d) a plant or plant cell genetically 
identical to the subject plant or plant cell but which is not 
exposed to conditions or stimuli that would induce the innate 
immune response of the plant to a biotic stress; or (e) the 
subject plant or plant cell itself, under conditions in which 
the gene of interest (HopU1 or HopU1 substrate) is not 
expressed. 
I. Method of Suppressing the Innate Immune Response of a 
Plant. 
0049) To date, to the inventor's knowledge, ADP-RTs 
have not been implicated in the Suppression of the innate 
immune response. Furthermore, genes that encode ADP-RTs 
have been found in eukaryotes but have not been identified 
in plants (Corda, D. & Di Girolamo, M. Functional aspects 
of protein mono-ADP-ribosylation. EMBO 22, 1953-1958 
(2003)). In one aspect, the present invention provides a 
method for Suppressing the innate immune response of a 
plant. In one aspect, the method includes expressing or 
over-expressing a polynucleotide that encodes a HopU1 
polypeptide with HopU1 activity in a prokaryotic or eukary 
otic cell, for example, a bacterial, plant or animal cell. As 
used herein, the term “over-express' or “over-expressing 
refers to the production of a HopU1 polypeptide in a plant 
cell in amounts exceeding that normally produced in the 
plant or animal cell. 
0050 Polypeptides of HopU1 preferably possess one or 
more of the bioactivities of the HopU1 protein, including 
ADP-ribosylating a substrate in vitro or in vivo, acting to 
Suppress the innate immune response of a plant as provided 
by the present invention. Also, included for use in the 
present invention are HopU1 substrate polypeptides that are 
targets of HopU1 that Suppress the innate immune response 
of a plant when ADP-ribosylated by HopU1 or enhance the 
innate immune system when over-expressed in a plant cell 
or plant. It is also contemplated that certain residues of the 
HopU1 substrate may be altered to prevent ADP-ribosyla 
tion by HopU1. 
0051. In one aspect of the invention, the protein may be 
a HopU1 polypeptide, a variant HopU1 polypeptide and/or 
have additional amino acid molecules, such as amino acid 
residues (contiguous encoded sequence) that are naturally 
associated with it or heterologous amino acid residues/ 
peptide sequences. Such a protein can have a few additional 
amino acid residues or can comprise several hundred or 
more additional amino acids. Fragments of the HopU1 
polypeptide, for example, a fragment that comprises at least 
8 or more contiguous amino acid residues from a HopU1 
polypeptide or variant protein as described herein, that retain 
one or more of the biological activities of a HopU1 polypep 
tide, for example, ADP-ribosylating a substrate in vitro or in 
Vivo, and/or acting to suppress the innate immune response 
of a plant or animal as provided by the present invention. 
Also included, therefore, are variants or fragments of the 
HopU1 polypeptide that encodes a polypeptide having a 
ADP-RT active (catalytic) site, in the conserved region 3 
with glutamic acids at positions 233 and 235 (FIG.1a), that 
correlates with ribosylation activity of a HopU1 substrate. 
Such a domain can be identified on the basis of sequence 
similarity with HopU1 ADP-RT domain and other proteins 
with ADP-RT domains (e.g., Cholera toxin), especially over 
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critical conserved residues. Additional HopU1 polypeptides, 
variants or fragments may include those with Substitutions, 
deletions, or insertions, as compared to a known sequence, 
for example HopU1, including those that alter HopU1 
activity. 
0052 The polynucleotides encoding polypeptides with 
HopU1 activity can be prepared by any suitable technique in 
the art, including synthesis or amplification as described in 
example 3. As described above, HopU1 polypeptides may be 
variants or fragments of HopU1. Any of these can be 
attached to heterologous sequences to form chimeric or 
fusion proteins for use in methods of the present invention. 
Such chimeric and fusion proteins comprise a Hop1 
polypeptide operatively linked to a heterologous protein 
having an amino acid sequence not substantially homolo 
gous to the variant protein. “Operatively linked' indicates 
that the variant protein and the heterologous protein are 
fused in-frame. The heterologous protein can be fused to the 
N-terminus or C-terminus of the HopU1 polypeptide, vari 
ant or fragment of HopU1. 
0053 A chimeric or fusion protein can be produced by 
standard recombinant DNA techniques. For example, DNA 
fragments coding for the different protein sequences are 
ligated together in-frame in accordance with conventional 
techniques. In another embodiment, the fusion gene can be 
synthesized by conventional techniques including auto 
mated DNA synthesizers. Alternatively, PCR amplification 
of gene fragments can be carried out using anchor primers 
which give rise to complementary overhangs between two 
consecutive gene fragments which can Subsequently be 
annealed and re-amplified to generate a chimeric gene 
sequence (see Ausubel et al., Current Protocols in Molecular 
Biology, 1992). Moreover, many expression vectors are 
commercially available that already encode a fusion moiety 
(e.g., a GST protein). A variant protein-encoding nucleic 
acid can be cloned into Such an expression vector Such that 
the fusion moiety is linked in-frame to the variant protein. 
0054 Polypeptides sometimes contain amino acids other 
than the 20 amino acids commonly referred to as the 20 
naturally occurring amino acids. Further, many amino acids, 
including the terminal amino acids, may be modified by 
natural processes, such as processing and other post-trans 
lational modifications, or by chemical modification tech 
niques well known in the art. Common modifications that 
occur naturally in polypeptides are described in basic texts, 
detailed monographs, and the research literature, and they 
are well known to those of skill in the art. Accordingly, the 
variant peptides of the present invention also encompass 
derivatives or analogs in which a Substituted amino acid 
residue is not one encoded by the genetic code, in which a 
Substitute group is included, in which the mature polypep 
tide is fused with another compound. Such as a compound to 
increase the half-life of the polypeptide (for example, poly 
ethylene glycol), or in which the additional amino acids are 
fused to the mature polypeptide, Such as a leader or secretory 
sequence or a sequence for purification of the mature 
polypeptide or a pro-protein sequence. 
0055. The polynucleotides encoding polypeptides with 
HopU1 activity can be obtained using methods that are 
known to those of skill in the art. Suitable nucleic acids (e.g., 
cDNA, genomic, microRNAs or RNAi, or subsequences) 
can be cloned, or amplified by in vitro methods such as the 
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polymerase chain reaction (PCR) using Suitable primers, the 
ligase chain reaction (LCR), the transcription-based ampli 
fication system (TAS), the self-sustained sequence replica 
tion system (SSR). A wide variety of cloning and in vitro 
amplification methodologies are well-known to persons of 
skill. Examples of these techniques and instructions Sufi 
cient to direct persons of skill through many cloning exer 
cises are found in Berger and Kimmel, Guide to Molecular 
Cloning Techniques, Methods in Enzymology 152 Academic 
Press, Inc., San Diego, Calif. (Berger); Sambrook et al. 
(1989) Molecular Cloning A Laboratory Manual (2nd ed.) 
Vol. 1-3, Cold Spring Harbor Laboratory, Cold Spring 
Harbor Press, NY. (Sambrook et al.); Current Protocols in 
Molecular Biology, F. M. Ausubel et al., eds., Current 
Protocols, a joint venture between Greene Publishing Asso 
ciates, Inc. and John Wiley & Sons, Inc., (1994 Supplement) 
(Ausubel); Cashion et al., U.S. Pat. No. 5,017,478; and Carr, 
European Patent No. 0.246,864. Examples of techniques 
sufficient to direct persons of skill through in vitro ampli 
fication methods are found in Berger, Sambrook, and 
Ausubel, as well as Mullis et al., (1987) U.S. Pat. No. 
4,683.202, PCR Protocols A Guide to Methods and Appli 
cations (Innis et al., eds) Academic Press Inc. San Diego, 
Calif. (1990) (Innis); Amheim & Levinson (Oct. 1, 1990) 
C&EN 36-47: The Journal Of NIH Research (1991) 3:81– 
94; (Kwoh et al. (1989) Proc. Natl. Acad. Sci. USA 86:1173: 
Guatelli et al. (1990) Proc. Natl. Acad. Sci. USA 87: 1874; 
Lomell et al. (1989).J. Clin. Chem., 35:1826; Landegren et 
al., (1988) Science 241:1077-1080; Van Brunt (1990) Bio 
technology 8:291-294: Wu and Wallace (1989) Gene 4:560; 
and Barringer et al. (1990) Gene 89:117. 
0056. One of skill would recognize that modifications 
could be made to a HopU1 or HopU1 substrate polypeptide 
or protein without diminishing its biological activity. Some 
modifications may be made to facilitate the cloning, expres 
Sion, or incorporation of the targeting molecule into a fusion 
protein. Such modifications are well known to those of skill 
in the art and include, for example, a methionine added at the 
amino terminus to provide an initiation site, or additional 
amino acids (e.g., poly His) placed on either terminus to 
create conveniently located restriction sites or termination 
codons or purification sequences. 
0057 Modifications to the HopU1 or HopU1 substrate 
polypeptide or protein also include but are not limited to 
conservative amino acid substitutions and those that are 
Ophenotypically silent. Conservative substitutions are the 
replacements, one for another, among the aliphatic amino 
acids Ala, Val, Leu, and Ile; interchange of the hydroxyl 
residues Ser and Thr, exchange of the acidic residues Asp 
and Glu, substitution between the amide residues Asn and 
Gln, exchange of the basic residues Lys and Arg and 
replacements among the aromatic residues Phe, Tyr and Trp. 
Guidance concerning which amino acid changes are likely to 
be phenotypically silent is found in Bowie et al., Science 
247: 1306 1310 (1990). 
0.058 Expression cassettes and vectors and in vitro cul 
ture methods for plant cell or tissue transformation and 
regeneration of plants are known and available. See, e.g., 
Gruber et al., “Vectors for Plant Transformation,” in Meth 
ods in Plant Molecular Biology and Biotechnology, Supra, 
pp. 89-119. A polynucleotide encoding a polypeptide with 
HopU1 activity or a HopU1 substrate may be introduced 
into either a prokaryotic or eukaryotic plant or animal host 
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cell through the use of a vector, plasmid or construct, or 
TTSS, such as P. Syringae or P aeruginosa. An expression 
cassette may contain a promoter operably linked to a nucleic 
acid that encodes the polypeptide. Cells are transfected with 
an expression vector for the polynucleotide encoding a 
polypeptide with HopU1 activity or a HopU1 substrate, or 
variant or fragment thereof, and if desired the effect on ADP 
ribosylation may be measured by a suitable method, such as 
the assays described herein. The expression cassettes are 
typically included on expression vectors that are introduced 
into Suitable host cells, including for example, bacterial, 
insect, fungal, plant or animal cells. For example, plant 
expression vectors may include a cloned plant gene under 
the transcriptional control of 5' and 3' regulatory sequences 
and a dominant selectable marker. Such plant expression 
vectors may also contain, if desired, a promoter regulatory 
region (e.g., one conferring inducible or constitutive, envi 
ronmentally- or developmentally-regulated, or cell- or tis 
Sue-specific/selective expression), a transcription initiation 
start site, a ribosome binding site, an RNA processing signal, 
a transcription termination site, and/or a polyadenylation 
signal. 
0059. The expression vectors of the invention can be 
transferred into the chosen eukaryotic host cell by methods 
known to those of ordinary skill in the art including, for 
example, calcium phosphate transfection, DEAE-dextran 
mediated transfection, transvection, microinjection, cationic 
lipid-mediated transfection, electroporation, transduction, 
scrape loading, ballistic introduction, infection, Methods To 
Get Into Plant Cells or other methods. (See Molecule Clon ing: A Laboratory Manual, 2" ed., Vol. 1-3, ed. Sambrook 
et al., Cold Spring Harbor Laboratory Press (1989)). Trans 
formed cells can be selected, for example, by resistance to 
antibiotics conferred by genes contained on the plasmids, 
Such as the amp, gpt, neo and hyg genes. 
0060 Numerous methods for introducing foreign genes 
into plants are known and can be used to insert a HopU1 or 
HopU1 Substrate polynucleotide into a plant host, including 
biological and physical plant transformation protocols. See, 
e.g., Miki et al., “Procedure for Introducing Foreign DNA 
into Plants, in Methods in Plant Molecular Biology and 
Biotechnology, Glick and Thompson, eds. CRC Press, Inc., 
Boca Raton, pp. 67-88 (1993). The methods chosen vary 
with the host plant, and include chemical transfection meth 
ods such as calcium phosphate, microorganism-mediated 
gene transfer Such as Agrobacterium (Horsch et al., Science 
227: 1229-31 (1985)), electroporation, micro-injection, and 
biolistic bombardment. 
0061 Transformation protocols as well as protocols for 
introducing polypeptides or polynucleotide sequences into 
plants may vary depending on the type of plant or plant cell, 
i.e., monocot or dicot, targeted for transformation. Suitable 
methods of introducing polypeptides and polynucleotides 
into plant cells include microinjection (Crossway et al. 
(1986) Biotechniques 5:320–335), electroporation (Riggs et 
al. (1986) Proc. Natl. Acad. Sci. USA 83:5602-5606, Agro 
bacterium-mediated transformation (Townsend et al., U.S. 
Pat. No. 5,563,055; Zhao et al., U.S. Pat. No. 5,981,850), 
direct gene transfer (Paszkowski et al. (1985) EMBO J. 
3:2717-2722), and ballistic particle acceleration (see, for 
example, Sanford et al., U.S. Pat. No. 5,955.050; Tomes et 
al., U.S. Pat. No. 5,879,918: Tomes et al., U.S. Pat. No. 
5,886.255; Bidney et al., U.S. Pat. No. 5,932,782; Tomes et 
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al. (1995) “Direct DNA Transfer into Intact Plant Cells via 
Microprojectile Bombardment,” in Plant Cell, Tissue, and 
Organ Culture. Fundamental Methods, ed. Gamborg and 
Phillips (Springer-Verlag, Berlin); McCabe et al. (1988) 
Biotechnology 6:923-926); and Lec1 transformation 
(WO00/28058). Also see Weissinger et al. (1988) Ann. Rev. 
Genet. 22:521-577; Sanford et al. (1987) Particulate Science 
and Technology 5:27-37 (onion); Christou et al. (1988) Plant 
Physiol. 87:671-675 (soybean); McCabe et al. (1988) Bio/ 
Technology 6:923-926 (soybean); Finer and McMullen 
(1991) In Vitro Cell Dev. Biol. 27P:175-182 (soybean); 
Singh et al. (1998) Theor. Appl. Genet. 96:319-325 (soy 
bean); Datta et al. (1990) Biotechnology 8:736-750 (rice); 
Klein et al. (1988) Proc. Natl. Acad. Sci. USA 85:5305-5309 
(maize): Klein et al. (1988) Biotechnology 6:559-563 
(maize): Tomes, U.S. Pat. No. 5.250,855; Buising et al., U.S. 
Pat. Nos. 5,322,783 and 5.325,656: Tomes et al. (1995) 
“Direct DNA Transfer into Intact Plant Cells via Micro 
projectile Bombardment,” in Plant Cell, Tissue, and Organ 
Culture Fundamental Methods, ed. Gamborg (Springer 
Verlag, Berlin) (maize): Klein et al. (1988) Plant Physiol. 
91:550-555 (maize): Fromm et al. (1990) Biotechnology 
8:833-839 (maize): Hooykaas-Van Slogteren et al. (1985) 
Nature (London) 311:763-765: Bowen et al., U.S. Pat. No. 
5,736,369 (cereals); Bytebier et al. (1987) Proc. Natl. Acad. 
Sci. USA 85:5355-5359 (Liliaceae); De Wet et al. (1985) in 
The Experimental Manipulation of Ovule Tissues, ed. Chap 
man et al. (Longman, New York), pp. 197-209 (pollen); 
Kaeppler et al. (1990) Plant Cell Reports 9:515-518 and 
Kaeppler et al. (1992) Theor. Appl. Genet. 85:560-566 
(whisker-mediated transformation); D Halluin et al. (1992) 
Plant Cell 5:1595-1505 (electroporation); Li et al. (1993) 
Plant Cell Reports 12:250-255 and Christou and Ford 
(1995) Annals of Botany 75:507-513 (rice); Osjoda et al. 
(1996) Nature Biotechnology 15:755-750 (maize via Agro 
bacterium tumefaciens); Leelavathi et al. (2004) Plant Cell 
Reports 22:465-470 (cotton via Agrobacterium tumefa 
ciens); Kumar et al. (2004) Plant Molecular Biology 56:203 
216 (cotton plastid via bombardment); all of which are 
herein incorporated by reference. 
0062. As used herein “promoter' includes reference to a 
region of DNA upstream from the start of transcription and 
involved in recognition and binding of RNA polymerase and 
other proteins to initiate transcription. A “plant promoter is 
a promoter capable of initiating transcription in plant cells. 
Exemplary plant promoters include, but are not limited to, 
those that are obtained from plants, plant viruses, and 
bacteria which comprise genes expressed in plant cells Such 
Agrobacterium or Rhizobium. Examples are promoters that 
preferentially initiate transcription in certain tissues. Such as 
leaves, roots, seeds, fibers, Xylem vessels, tracheids, or 
sclerenchyma. Such promoters are referred to as “tissue 
preferred. A “cell type' specific promoter primarily drives 
expression in certain cell types in one or more organs, for 
example, vascular cells in roots or leaves. An “inducible' or 
“regulatable' promoter is a promoter, which is under envi 
ronmental control. Examples of environmental conditions 
that may effect transcription by inducible promoters include 
anaerobic conditions or the presence of light. 
0063 Another type of promoter is a developmentally 
regulated promoter, for example, a promoter that drives 
expression during pollen development. Examples of pollens 
specific promoters include but are not limited to a pollen 
specific pectate lyase gene promoter or PG47 gene promoter, 
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an another specific RTS2 gene promoter, SGB6 gene pro 
moter, or G9 gene promoter. Tissue preferred, cell type 
specific, developmentally regulated, and inducible promot 
ers constitute the class of “non-constitutive' promoters. A 
“constitutive' promoter is a promoter, which is active under 
most environmental conditions. Induced expression can also 
be achieved using chemicals such as estradiol using induc 
ible vector Per8 (Jianru Zuo, Qi-Wen Niu, Nam-Hai Chua 
(2000) An estrogen receptor-based transactivator XVE 
mediates highly inducible gene expression in transgenic 
plants. The Plant Journal 24 (2), 265-273. doi:10.1046/ j.1365-313x2000.00868.x). 
0064. A number of promoters can be used in the practice 
of the invention, including the native promoter of the HopU1 
or HopU1 Substrate polynucleotide sequence, for example, 
the promoter of the HopU1 substrate of the crop plant of 
interest. The promoters can be selected based on the desired 
outcome. The HopU1 or HopU1 substrate polynucleotide 
can be combined with constitutive, tissue-preferred, induc 
ible, or other promoters for expression in plants. 
0065. A plant promoter or promoter fragment can be 
employed which will direct expression of a polynucleotide 
of the present invention in all tissues of a regenerated plant. 
Such promoters are referred to herein as “constitutive' 
promoters and are active under most environmental condi 
tions and states of development or cell differentiation. 
Examples of constitutive promoters include the 1'- or 2'-pro 
moter derived from T-DNA of Agrobacterium tumefaciens, 
the Smas promoter, the cinnamyl alcohol dehydrogenase 
promoter (U.S. Pat. No. 5,683.439), the Nos promoter, the 
rubisco promoter, the GRP1-8 promoter, the 35S promoter 
from cauliflower mosaic virus (CaMV), as described in 
Odell, et al., (1985) Nature 313:810-2: rice actin (McElroy, 
et al., (1990) Plant Cell 163-171); ubiquitin (Christensen, et 
al., (1992) Plant Mol. Biol. 12:619-632 and Christensen, et 
al., (1992) Plant Mol. Biol. 18:675-89); pEMU (Last, et al., 
(1991) Theor: Appl. Genet. 81:581-8); MAS (Velten, et al., 
(1984) EMBO.J. 3:2723-30); and maize H3 histone (Lepetit, 
et al., (1992) Mol. Gen. Genet. 231:276-85; and Atanassvoa, 
et al., (1992) Plant Journal 2(3):291-300); ALS promoter, as 
described in PCT Application No. WO 96/30530; and other 
transcription initiation regions from various plant genes 
known to those of skill. For the present invention ubiquitin 
is the preferred promoter for expression in monocot plants. 
0066 Tissue-preferred promoters can be utilized to target 
enhanced type A RR expression within a particular plant 
tissue. By “tissue-preferred' is intended to mean that expres 
sion is predominately in a particular tissue, albeit not nec 
essarily exclusively in that tissue. Tissue-preferred promot 
ers include Yamamoto et al. (1997) Plant J. 12(2):255-265; 
Kawamata et al. (1997) Plant Cell Physiol. 38(7):792-803; 
Hansen et al. (1997) Mol. Gen. Genet. 255(3):337-353; 
Russellet al. (1997) Transgenic Res. 6(2): 157-168; Rinehart 
et al. (1996) Plant Physiol. 112(3):1331-1351; Van Camp et 
al. (1996) Plant Physiol. 112(2):525-535; Canevascini et al. 
(1996) Plant Physiol. 112(2):513-525; Yamamoto et al. 
(1995) Plant Cell Physiol. 35(5):773-778; Lam (1995) 
Results Probl. Cell Differ. 20:181-196; Orozco et al. (1993) 
Plant Mol. Biol. 23(6): 1129-1138; Matsuoka et al. (1993) 
Proc Natl. Acad. Sci. USA 90(20):9586-9590; and Guevara 
Garcia et al. (1993) Plant J. 5(3):595-505. Such promoters 
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can be modified, if necessary, for weak expression. See, also, 
U.S. Patent Application No. 2003/0074698, herein incorpo 
rated by reference. 
0067 Expression of HopU1 and over-expression of 
HopU1 substrates may be achieved by any number of 
methods, including but not limited to transient transfection, 
integration, gene amplification, plant transformation or any 
other molecular process which results in amounts of HopU1 
polypeptide exceeding those amounts typically found in the 
host cell as described elsewhere in the application. The 
typical range of expression in a given cell type can be 
determined by routine techniques as by assaying the HopU1 
protein, its mRNA, or its gene. 
0068. The expression level of the HopU1 or HopU1 
Substrate polypeptide may be measured directly, for 
example, by assaying for the level of the HopU1 or HopU1 
Substrate polypeptide in the plant, or indirectly, for example, 
by measuring the HopU1 activity of the HopU1 or HopU1 
substrate polypeptide in the plant. Methods for determining 
the HopU1 or HopU1 substrate expression or activity may 
be determined using standard techniques or assays such as 
immunoassay, PAGE, western blot, Southern and Northern 
blots, and competition hybridization procedures and Y. 
including the evaluation of ADP-RT activity in vitro or in 
Vivo in various expression systems. 
0069. Functional assays for ADP-ribosyltransferase can 
be conducted by incubating the HopU1 polypeptide with a 
target protein (such as the poly-L-arginine (see Example 7)), 
or a known substrate of HopU1, such as AtGRP7 and 
AtGRP8 (See Table 1) in the presence of nicotinamide 
adenine dinucleotide (NAD"), or an analog labeled with a 
radioisotope such as P or P. biotin, or a fluorescent 
group. (186) ADP-ribosylation can be monitored by incor 
poration of the label into the protein phase, by a change of 
size of the target protein (measurable, for example on a 
protein gel), or by detection of ADP ribose polymers on the 
target (for example, using commercially available antibody 
specific for ADP-ribose polymers, or by physical-chemical 
mechanisms, such as mass spectrometry). Known ADP-RT 
inhibitors like novobiocin can be used to verify the speci 
ficity of the assay. Polypeptides with confirmed ADP-RT 
activity can then be used in methods of the present inven 
tion, for example, Suppressing the innate immune system of 
a plant. 
0070 The evaluation of HopU1 expression may also 
include evaluation of phenotypic changes. Such as Sup 
pressed immune response in a plant Subjected to a biotic 
stress. Examples of phenotypic changes include but are not 
limited to the transfer of ADP-ribose of B-NAD onto a 
HopU1 substrate, HR and other outputs of innate immunity 
as described herein. As stated above, Suppression of the 
plants innate immune response may be achieved through 
expression of HopU1. Thus, modulation of HopU1 expres 
sion or activity in a plant or plant cell provides a novel 
strategy for Suppressing the immune system of a plant 
exposed to a biotic stress. 
0071 Methods are provided to reduce or eliminate the 
level and/or the activity of a HopU1 substrate polypeptide 
by transforming a plant cell with an expression cassette that 
expresses a polynucleotide that inhibits the expression of the 
HopU1 substrate polypeptide. As used herein, the term 
“under-express”, “under-expression' or “under-expressing 
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refers to the production of a HopU1 substrate polypeptide in 
a plant cell in amounts less than that normally produced in 
the plant or animal cell. 
0072 The polynucleotide may inhibit the expression of 
one or more HopU1 substrate polypeptides directly, by 
preventing translation of the HopU1 Substrate messenger 
RNA, or indirectly, by encoding a polypeptide that inhibits 
the transcription or translation of a plant gene encoding a 
HopU1 substrate polypeptide. Methods for inhibiting or 
eliminating the expression of a gene in a plant are well 
known in the art, and any Such method may be used in the 
present invention to inhibit the expression of one or more 
HopU1 substrate polypeptide. 
0073. In accordance with the present invention, the 
expression of a HopU1 substrate polypeptide is under 
expressed, decreased or inhibited if the protein level of the 
HopU1 Substrate polypeptide is statistically significantly 
lower than the protein level of the same HopU1 substrate 
polypeptide in a plant that has not been genetically modified 
or mutagenized to inhibit the expression of that protein. In 
particular embodiments of the invention, the protein level of 
the HopU1 substrate polypeptide in a modified plant accord 
ing to the invention is less than 96%, less than 90%, less than 
80%, less than 75%, less than 60%, less than 50%, less than 
40%, less than 30%, less than 20%, less than 10%, or less 
than 5% of the protein level of the same HopU1 substrate 
polypeptide in a plant that is not a mutant or that has not 
been genetically modified to inhibit the expression of that 
HopU1 substrate polypeptide. The expression level of the 
HopU1 substrate polypeptide may be measured directly, for 
example, by assaying for the level of HopU1 substrate 
polypeptide expressed in the plant cell or plant, or indirectly, 
for example, by measuring the activity of the HopU1 sub 
strate polypeptide in the plant cell or plant. Methods for 
determining the HopU1 substrate activity of HopU1 sub 
strate polypeptide are described elsewhere herein. 
0074. In other embodiments of the invention, the activity 
of one or more HopU1 substrate is reduced or eliminated by 
transforming a plant cell with an expression cassette com 
prising a polynucleotide encoding a polypeptide that inhibits 
the activity of one or more HopU1 substrates. The HopU1 
Substrate activity may be inhibited according to the present 
invention if the HopU1 substrate activity of the genetically 
modified plant is statistically significantly lower than the 
activity of the same HopU1 substrate in a plant that has not 
been genetically modified to inhibit the HopU1 substrate 
activity. In particular embodiments of the invention, the 
HopU1 substrate activity of the HopU1 substrate in a 
modified plant according to the invention is less than 95%, 
less than 90%, less than 80%, less than 70%, less than 60%, 
less than 50%, less than 40%, less than 30%, less than 20%, 
less than 10%, or less than 5% of the HopU1 substrate 
activity of the same HopU1 substrate in a plant that that has 
not been genetically modified to inhibit the expression of 
that HopU1 substrate. The HopU1 substrate activity of a 
HopU1 substrate is “eliminated according to the invention 
when it is not detectable by the assay methods described 
elsewhere herein. Methods of determining the HopU1 sub 
strate activity of a HopU1 substrate are described elsewhere 
herein. 
0075). In other embodiments, the activity of a HopU1 
substrate may be reduced or eliminated by disrupting the 
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gene encoding the HopU1 Substrate. The invention encom 
passes mutagenized plants that carry mutations in HopU1 
Substrate genes, where the mutations reduce expression of 
the HopU1 substrate gene or inhibit the HopU1 substrate 
activity of the encoded HopU1 substrate. 
0.076 Thus, many methods may be used to reduce or 
eliminate the activity of a HopU1 substrate. More than one 
method may be used to reduce the activity of a single HopU1 
Substrate. In addition, combinations of methods may be 
employed to reduce or eliminate the activity of two or more 
different HopU1 substrate polypeptides. 
0077. Non-limiting examples of methods of reducing or 
eliminating the expression of a HopU1 Substrate are given 
below. 
0078. In some embodiments of the present invention, a 
plant cell is transformed with an expression cassette that is 
capable of expressing a polynucleotide that inhibits the 
expression of HopU1 substrate polypeptides. The term 
“expression” as used herein refers to the biosynthesis of a 
gene product, including the transcription and/or translation 
of said gene product. For example, for the purposes of the 
present invention, an expression cassette capable of express 
ing a polynucleotide that inhibits the expression of at least 
one HopU1 Substrate polypeptide is an expression cassette 
capable of producing an RNA molecule that inhibits the 
transcription and/or translation of at least one HopU1 sub 
strate polypeptide. The “expression' or “production of a 
protein or polypeptide from a DNA molecule refers to the 
transcription and translation of the coding sequence to 
produce the protein or polypeptide, while the “expression 
or “production of a protein or polypeptide from an RNA 
molecule refers to the translation of the RNA coding 
sequence to produce the protein or polypeptide. 
0079. In some embodiments of the invention, inhibition 
of the expression of a HopU1 substrate polypeptide may be 
obtained by sense Suppression or coSuppression. For coSup 
pression, an expression cassette is designed to express an 
RNA molecule corresponding to all or part of a messenger 
RNA encoding a HopU1 substrate polypeptide in the 
“sense' orientation. Over-expression of the RNA molecule 
can result in reduced expression of the native gene. Accord 
ingly, multiple plant lines transformed with the coSuppres 
sion expression cassette are screened to identify those that 
show the greatest inhibition of HopU1 substrate polypeptide 
expression. 
0080. The polynucleotide used for cosuppression may 
correspond to all or part of the sequence encoding the 
HopU1 substrate polypeptide, all or part of the 5' and/or 3' 
untranslated region of a HopU1 Substrate transcript, or all or 
part of both the coding sequence and the untranslated 
regions of a transcript encoding HopU1 Substrate polypep 
tide. In some embodiments where the polynucleotide com 
prises all or part of the coding region for the HopU1 
Substrate polypeptide, the expression cassette is designed to 
eliminate the start codon of the polynucleotide so that no 
protein product will be transcribed. 
0081 Cosuppression may be used to inhibit the expres 
sion of plant genes to produce plants having undetectable 
protein levels for the proteins encoded by these genes. See, 
for example, Broin et al. (2002) Plant Cell 15:1517-1532. 
CoSuppression may also be used to inhibit the expression of 
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multiple proteins in the same plant. See, for example, U.S. 
Pat. No. 5,952,657. Methods for using cosuppression to 
inhibit the expression of endogenous genes in plants are 
described in Flavellet al. (1995) Proc. Natl. Acad. Sci. USA 
91:3590-3596: Jorgensen et al. (1996) Plant Mol. Biol. 
31:957-973: Johansen and Carrington (2001) Plant Physiol. 
126:930-938: Broin et al. (2002) Plant Cell 15:1517-1532: 
Stoutjesdijk et al (2002) Plant Physiol. 129: 1723-1731: Yu 
et al. (2003) Phytochemistry 63:753-763; and U.S. Pat. Nos. 
5,035,323, 5,283,185, and 5,952,657; each of which is 
herein incorporated by reference. The efficiency of cosup 
pression may be increased by including a poly-dT region in 
the expression cassette at a position 3' to the sense sequence 
and 5' of the polyadenylation signal. See, U.S. Patent 
Publication No. 20020058815, herein incorporated by ref 
erence. Typically, such a nucleotide sequence has substantial 
sequence identity to the sequence of the transcript of the 
endogenous gene, optimally greater than about 65% 
sequence identity, more optimally greater than about 85% 
sequence identity, most optimally greater than about 95% 
sequence identity. See, U.S. Pat. Nos. 5.283,185 and 5,035, 
323; herein incorporated by reference. 
0082 Transcriptional gene silencing (TGS) may be 
accomplished through use of hpRNA constructs wherein the 
inverted repeat of the hairpin shares sequence identity with 
the promoter region of a gene to be silenced. Processing of 
the hpRNA into short RNAs which can interact with the 
homologous promoter region may trigger degradation or 
methylation to result in silencing. (Aufsatz et al. (2002) 
PNAS 99 (Suppl. 4): 16499-16506; Mette et al. (2000) 
EMBOJ 19(19):5194-5201) See also U.S. Patent Publica 
tion 2005/0246796. 
0083. In some embodiments of the invention, inhibition 
of the expression of the HopU1 substrate polypeptide may 
be obtained by antisense Suppression. For antisense Suppres 
Sion, the expression cassette is designed to express an RNA 
molecule complementary to all or part of a messenger RNA 
encoding the HopU1 substrate polypeptide. Over-expression 
of the antisense RNA molecule can result in reduced expres 
sion of the native gene. Accordingly, multiple plant lines 
transformed with the antisense Suppression expression cas 
sette are screened to identify those that show the greatest 
inhibition of HopU1 substrate polypeptide expression. 
0084. The polynucleotide for use in antisense suppres 
sion may correspond to all or part of the complement of the 
sequence encoding the HopU1 Substrate polypeptide, all or 
part of the complement of the 5' and/or 3' untranslated region 
of the HopU1 substrate polypeptide transcript, or all or part 
of the complement of both the coding sequence and the 
untranslated regions of a transcript encoding the HopU1 
Substrate polypeptide. In addition, the antisense polynucle 
otide may be fully complementary (i.e., 100% identical to 
the complement of the target sequence) or partially comple 
mentary (i.e., less than 100% identical to the complement of 
the target sequence) to the target sequence. Antisense Sup 
pression may be used to inhibit the expression of multiple 
proteins in the same plant. See, for example, U.S. Pat. No. 
5,952,657. Furthermore, portions of the antisense nucle 
otides may be used to disrupt the expression of the target 
gene. Generally, sequences of at least 50 nucleotides, 100 
nucleotides, 200 nucleotides, 300, 400, 450, 500, 550, or 
greater may be used. Methods for using antisense Suppres 
sion to inhibit the expression of endogenous genes in plants 
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are described, for example, in Liu et al (2002) Plant Physiol. 
129: 1732-1753 and U.S. Pat. Nos. 5,759,829 and 5,952,657. 
Efficiency of antisense Suppression may be increased by 
including a poly-dT region in the expression cassette at a 
position 3' to the antisense sequence and 5' of the polyade 
nylation signal. See U.S. Patent Publication No. 2002/ 
O058815. 
0085. In some embodiments of the invention, inhibition 
of the expression of a HopU1 substrate polypeptide may be 
obtained by double-stranded RNA (dsRNA) interference. 
For dsRNA interference, a sense RNA molecule like that 
described above for cosuppression and an antisense RNA 
molecule that is fully or partially complementary to the 
sense RNA molecule are expressed in the same cell, result 
ing in inhibition of the expression of the corresponding 
endogenous messenger RNA. 
0.086 Expression of the sense and antisense molecules 
can be accomplished by designing the expression cassette to 
comprise both a sense sequence and an antisense sequence. 
Alternatively, separate expression cassettes may be used for 
the sense and antisense sequences. Multiple plant lines 
transformed with the dsRNA interference expression cas 
sette or expression cassettes are then screened to identify 
plant lines that show the greatest inhibition of HopU1 
substrate polypeptide expression. Methods for using dsRNA 
interference to inhibit the expression of endogenous plant 
genes are described in Waterhouse et al. (1998) Proc. Natl. 
Acad. Sci. USA 95:13959-13965, Liu et al. (2002) Plant 
Physiol. 129:1732-1753, and WO 99/59029, WO 99/53050, 
WO99/61631, and WO 00/59035. 
0087. In some embodiments of the invention, inhibition 
of the expression of one or more type A RR polypeptide may 
be obtained by hairpin RNA (hpRNA) interference or intron 
containing hairpin RNA (ihpRNA) interference. These 
methods are highly efficient at inhibiting the expression of 
endogenous genes. See, Waterhouse and Helliwell (2003) 
Nat. Rev. Genet. 5:29-38 and the references cited therein. 
0088 For hpRNA interference, the expression cassette is 
designed to express a RNA molecule that hybridizes with 
itself to form a hairpin structure that comprises a single 
Stranded loop region and a base-paired stem. The base 
paired stem region comprises a sense sequence correspond 
ing to all or part of the endogenous messenger RNA 
encoding the gene whose expression is to be inhibited, and 
an antisense sequence that is fully or partially complemen 
tary to the sense sequence. Thus, the base-paired stem region 
of the molecule generally determines the specificity of the 
RNA interference. hpRNA molecules are highly efficient at 
inhibiting the expression of endogenous genes, and the RNA 
interference they induce is inherited by Subsequent genera 
tions of plants. See, for example, Chuang and Meyerowitz 
(2000) Proc. Natl. Acad. Sci. USA 97:5985-5990; Stoutes 
dijk et al. (2002) Plant Physiol. 129: 1723-1731; and Water 
house and Helliwell (2003) Nat. Rev. Genet. 5:29-38. Meth 
ods for using hpRNA interference to inhibit or silence the 
expression of genes are described, for example, in Chuang 
and Meyerowitz (2000) Proc. Natl. Acad. Sci. USA 97:5985 
5990; Stoutjesdijk et al. (2002) Plant Physiol. 129: 1723 
1731: Waterhouse and Helliwell (2003) Nat. Rev. Genet. 
5:29-38; Pandolfini et al. BMC Biotechnology 3:7, and U.S. 
Patent Publication No. 2003.0175965; each of which is 
herein incorporated by reference. A transient assay for the 
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efficiency of hpRNA constructs to silence gene expression in 
vivo has been described by Panstruga et al. (2003) Mol. Biol. 
Rep. 30:135-150. 
0089 For ihpRNA, the interfering molecules have the 
same general structure as for hpRNA, but the RNA molecule 
additionally comprises an intron that is capable of being 
spliced in the cell in which the ihpRNA is expressed. The use 
of an intron minimizes the size of the loop in the hairpin 
RNA molecule following splicing, and this increases the 
efficiency of interference. See, for example, Smith et al. 
(2000) Nature 507:319-320. In fact, Smith et al. show 100% 
Suppression of endogenous gene expression using ihpRNA 
mediated interference. Methods for using ihpRNA interfer 
ence to inhibit the expression of endogenous plant genes are 
described, for example, in Smith et al. (2000) Nature 
507:319-320; Wesley et al. (2001) Plant J. 27:581-590; 
Wang and Waterhouse (2001) Curr. Opin. Plant Biol. 5:156 
150; Waterhouse and Helliwell (2003) Nat. Rev. Genet. 
5:29-38: Helliwell and Waterhouse (2003) Methods 30:289 
295, and U.S. Patent Publication No. 20030180955. 
0090 The expression cassette for hpRNA interference 
may also be designed Such that the sense sequence and the 
antisense sequence do not correspond to an endogenous 
RNA. In this embodiment, the sense and antisense sequence 
flank a loop sequence that comprises a nucleotide sequence 
corresponding to all or part of the endogenous messenger 
RNA of the target gene. Thus, it is the loop region that 
determines the specificity of the RNA interference. See, for 
example, WO 02/00905. 
0091 Suppression or enhancement of the immune 
response of a plant to a biotic stress may be determined or 
inferred from evaluating outputs of innate immunity, using 
any number of methods including those as described herein. 
See Example 7. Once animal or plant immune systems 
perceive biotic stresses, such as PAMPs or AVR proteins or 
other viral, fungal, and bacterial pathogens, signal transduc 
tion pathways are triggered and defense-related outputs are 
deployed. Examples of physiological responses that occur in 
plants after activation of innate immunity include the gen 
eration of reactive oxygenation species (ROS) and nitric 
oxide (NO), changes in cytoplasmic Ca2+ levels, production 
of pathogen-related (PR) gene expression, phytoalexin pro 
duction, papillae formation (i.e. thickening of the cell wall), 
and callose (B-1-3 glucan deposition) in the cell wall. 
(Dangl, J. L., and J. D. Jones. Plant pathogens and integrated 
defence responses to infection. Nature 411:826-833 (2001); 
Gomez-Gomez, L., and T. Boller. Flagellin perception: a 
paradigm for innate immunity. Trends Plant Sci. 7:251-256 
(2002); Heath, M. C. Nonhost resistance and nonspecific 
plant defenses. Curr. Opin. Plant Biol. 0.3:315-319 (2000); 
and Jones, D. A., and D. Takemoto. Plant innate immunity— 
direct and indirect recognition of general and specific patho 
gen-associated molecules. Curr. Opin. Immunol. 16:48-62 
(2004)), or the hyperSensitive response, a programmed cell 
death response similar to apoptosis in. (Goodman, R.N., and 
A. J. Novacky. The hypersensitive reaction of plants to 
pathogens: A resistance phenomenon. APS Press, St. Paul 
(1994); and Heath, M. C. Hypersensitive response-related 
death. Plant Mol. Biol. 44:321-33 (2000)). 
0092 Plants expressing or over-expressing HopU1 and/ 
or those with under-expressed or decreased levels of one or 
more HopU1 substrates are exposed to or challenged with a 
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biotic stress, for example, viral, fungal, and bacterial patho 
gens such as P. syringae tomato DC3000, Oomycete patho 
gen Peronospora parasitica (that causes Downy mildew), of 
flg22 and the Suppression of the innate immune system 
determined. Suppression of the innate immune system of a 
plant by HopU1 may be determined by evaluating callose 
deposition in a plant cell wall in a plant exposed to a biotic 
stress. Callose may be easily stained with a fluorescent dye 
aniline blue and levels assessed accordingly. (Adam, L., and 
S. C. Somerville. Genetic characterization of five powdery 
mildew disease resistance loci in Arabidopsis thaliana Plant 
J. 9:341-356 (1996)). Plants expressing or over-expressing 
HopU1, for example, HopU1 transgenic plants, will produce 
reduced amounts of callose, for example, significantly 
reduced amounts of callose, as compared to a control plant. 
The control plant may be a plant that does not have the 
expression or over-expression of HopU1 or one that is only 
exposed to a biotic stress. 
0093. Another way in which to evaluate the suppression 
of the innate immune system of a plant is through the 
production of reactive oxygen species (ROS). (Mittler, R. 
Oxidative stress, antioxidants and stress tolerance. Trends 
Plant Sci. 7:405-410 (2002)). Levels of ROS may be deter 
mined in plants or exposed to a biotic stress using any 
suitable technique, including but not limited to nitroblue 
tetrazolium (NBT) based assays or fluoroscent probe dichlo 
rohydrofluorescein diacetate (DCF-DA). NBT is a dye that 
form an insoluble blue precipitate in the presence of ROS 
that can be easily viewed. Leaves of a plant expressing or 
over-expressing HopU1 and exposed to the biotic stress may 
be painted with a solution of NBT as described in 33 
(Cessna, S. G. V. E. Sears, M. B. Dickman, and P. S. Low. 
Oxalic acid, a pathogenicity factor for Sclerotinia Sclerotio 
rum, suppresses the oxidative burst of the host plant. Plant 
Cell 12:2191-2200 (2000)). Likewise, DCF-DA is oxidized 
by ROS in cells and yields the green fluoroscent product 
DCF that can be viewed with fluorescence microscopy. 
(LeBel, C. P. H. Ischiropoulos, and S. C. Bondy. Evaluation 
of the probe 2,7'-dichlorofluorescin as an indicator of reac 
tive oxygen species formation and oxidative stress. Chem. 
Res. Toxicol. 5:227-231 (1992)). Plants expressing or over 
expressing HopU1, for example, HopU1 transgenic plants, 
may produce reduced amounts of ROS, for example, Sig 
nificantly reduced amounts of ROS, as compared to a control 
plant. The control plant may be a plant that does not have the 
expression or over-expression of HopU1 or one that is not 
exposed to a biotic stress. The proper positive and negative 
controls will be known to one of skill in the art. 
0094 Optionally, plants expressing HopU1 polypeptides 
and/or those with under-expressed or decreased levels of one 
or more HopU1 substrates may be evaluated for the disease 
symptoms of the pathogen and their ability to grow in these 
plants using standard techniques known in the art. (Petnicki 
Ocwieja, T., D. J. Schneider, V. C. Tam, S. T. Chancey, L. 
Shan, Y. Jamir, L. M. Schechter, M. D. Janes, C. R. Buell, 
X. Tang, A. Collmer, and J. R. Alfano. Genomewide iden 
tification of proteins secreted by the Hrp type III protein 
secretion system of Pseudomonas Syringae pv. tomato 
DC3000. Proc. Natl. Acad. Sci. USA99:7652-7657 (2002); 
and Wehling, M.D., M. Guo, Z. Q. Fu, and J. R. Alfano. The 
Pseudomonas Syringae HopPtoV protein is secreted in cul 
ture and translocated into plant cells via the type III protein 
secretion system in a manner dependent on the ShcV type III 
chaperone. J. Bacteriol. 186:3621-3630 (2004)). For 
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example, diseases symptoms and multiplication of the 
pathogen in planta may be determined at various time points 
as a measure of whether or not innate immunity is Sup 
pressed by over-expression of HopU1 in a plant and/or those 
plants with decreased levels of one or more HopU1 sub 
Strates. 
0095 HopU1 is less similar to other known Hops, shar 
ing only 21% identity to HopO1-1 and HopO1-2; however, 
additional polypeptides having HopU1 activity may be 
identified according to the invention. Those skilled in the art 
will readily appreciate that the assays described earlier in 
this section can be adapted to screen for other polypeptides 
that have HopU1 activity that may be involved in suppress 
ing the immune response, for example, to a biotic stress. 
This can be determined using a variety of methods and 
assays routine to one skilled in the art, for example, deter 
mining the ADP-ribosylation of a substrate of HopU1. 
Generally, a purified or partially purified candidate HopU1 
polypeptide is incubated with a peptide comprising the 
ADP-ribosylation target sequence of HopU1 under condi 
tions suitable for the HopU1 to ribosylate its target sequence 
of amino acids (i.e., protein, polypeptide). The particular 
conditions of the ADP-ribosylation may be determined 
empirically by one of skill in the art, or using the conditions 
that are described herein. The extent of ribosylation of the 
target Substrate peptide is determined in the presence and 
absence of the candidate HopU1 polypeptide. 
0096. Known HopU1 polynucleotides can be used to 
identify additional HopU1 polynucleotides in a sample of 
interest, for example by Northern, Southern or Western blot 
analysis. Polypeptides are conveniently obtained by trans 
lation in an in vitro translation system, or by expression in 
a suitable host cell. To produce an expression vector, a 
polynucleotide encoding the desired polypeptide is operably 
linked to control elements for transcription and translation, 
and then transfected into a suitable host cell. Expression may 
be effected in prokaryotes such as E. coli, eukaryotic micro 
organisms such as the yeast Saccharomyces cerevisiae, or 
higher eukaryotes, such as plant, insect or mammalian cells. 
Following production, the protein is typically purified from 
the producing host cell by standard methods in protein 
chemistry in an appropriate combination, which may include 
ion exchange chromatography, affinity chromatography, and 
HPLC. Expression products are optionally produced with a 
sequence tag to facilitate affinity purification, which can 
Subsequently be removed by proteolytic cleavage. 
0097 Such polypeptides can be tested, including but not 
limited to the characterization of Suppression of the immune 
response, assays for the identification of HopU1 ADP-RT 
activity. Variants, fragments or domains of HopU1 polypep 
tides can be assessed for HopU1 activity and employed in 
the methods of the present invention. 
0098. In another example, HopU1 is labeled with a 
traceable Substituent, such as biotin, a fluorescent group, an 
enzyme, a radioisotope, or a peptide group (e.g., FLG, HA, 
myc, or an immunoreactive peptide sequence), and then 
combined in a reaction Solution with an isolated candidate 
binding partner, or with a mixture of components (such as a 
cell extract) in which compounds with HopU1 binding 
activity may be found. Formation of complexes with the 
labeled HopU1 is then detected (for example, by gel shift 
techniques or immunoprecipitation), and correlated with 
binding activity for HopU1. 
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0099 Another approach is a co-expression system, using 
HopU1, a HopU1 fragment, or a candidate HopU1 polypep 
tide as bait. For example, a yeast two-hybrid Screen system 
is employed, in which a HopU1 encoding sequence is fused 
to one part of the expression system, and a library of 
candidate binding partners is fused to the complementary 
component needed for expression of the marker. Cloned 
cells that express the activity of the marker contain an insert 
that comprises the encoding sequence for a HopU1 binding 
partner. Yeast two-hybrid screen systems are described gen 
erally in Bianchi et al., EMBO J., 16:1785, 1997. Reagents 
and suitable libraries are commercially available. 
II. Method of Enhancing the Innate Immune Response of a 
Plant. 
0100. The invention is related to the discovery of HopU1 
substrates and the use of these substrates for the enhance 
ment of the innate immune response of a plant to a biotic 
stress. Exemplary HopU1 substrates are RNA-binding pro 
teins (RBPs) that are glycine-rich RNA-biding proteins 
(GR-RBPs) and chloroplast RNA-biding proteins (CP 
RBPs). The HopU1 substrates ADP-ribosylated by HopU1 
were identified in Arabidopsis thaliana and include three 
CP-RBPs and two glycine-rich RNA-binding proteins (GR 
RBPs). (See Table 1). To the inventor's knowledge, RNA 
binding proteins have not been described as a substrate for 
any ADP-RT, much less, HopU1. 
0101. In one aspect, the invention provides for a method 
of enhancing an innate immune system of a plant to a biotic 
stress. In one aspect, the method includes over-expressing a 
HopU1 substrate in a plant. In one aspect, the HopU1 
substrate is a RNA binding protein, including but not limited 
to a glycine rich RNA binding protein or a chloroplast RNA 
binding protein. The HopU1 substrate is capable of being 
ADP-ribosylated by HopU1. It is also contemplated that 
certain residues of the HopU1 substrate may be altered to 
prevent ADP-ribosylation by HopU1, including those 
located within the RRM. Such residues include arginines 
and may be located within the RBP's RNA-recognition 
motif (RRM). 
0102 RNA binding proteins have a conserved RNA 
Recognition Motif (RRM). Chloroplast RNA binding pro 
teins may have two RRMs and glycine rich RNA binding 
proteins may only have one RRM. The first RRM of 
cp29-like Chloroplast RBP (At2g,377220.1) is from position 
92 to position 165 and the second RRM is from position 205 
to position 278. The first RRM of cp31-like Chloroplast RBP 
(At5g,50250.1) is from position 114 to position 187 and the 
second RRM is from position 207 to position 291. The first 
RRM of AtRBP31 Chloroplast RBP (Atag2477.1) is from 
position 151 to position 224 and the second RRM would be 
from position 245 to 318. The RRM can be found from 
position 9 to position 82 in AtGRP7 (At2g21660.1) and 
position 7 to position 80 in AtGRP8 (Atag39260.1). 
0103) The HopU1 substrate when over-expressed in a 
plant will enhance the innate immune response of a plant 
that is subjected to a biotic stress. Examples of HopU1 
substrates include but are not limited to cp29-like Chloro 
plast RBP (At2g377220.1) (accession numbers for protein 
and nucleotides are NP 181259 and NM 129278.3 respec 
tively), cp31-like Chloroplast RBP (At5g,50250.1) (acces 
sion numbers for protein and nucleotide are NP 199836 
and NM 124404.3, respectively). At RBP31 Chloroplast 
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RBP (Atag2477.1) (accession numbers for protein and 
nucleotide are NP 194208 and NM 118610.3, respec 
tively), Arabidopsis glycine rich RNA binding proteins 
AtGRP7 (accession numbers for the protein and nucleotide 
are NP 179760 and NM 127738, respectively), glycine 
rich RNA binding protein. At GRP8 (Atag39260.1) (acces 
sion numbers for protein and nucleotide are NP 195637 
and NM 120087.3, respectively) and variants thereof, 
including conserved amino acid Substitutions. 
0104. As described above, a polynucleotide of a HopU1 
Substrate may be introduced into either a prokaryotic or 
eukaryotic plant or animal host cell through the use of a 
vector, plasmid or construct. An expression cassette con 
taining a promoter operably linked to a nucleic acid that 
encodes the HopU1 substrate may be introduced into suit 
able host cells, including for example, bacterial, insect, 
fungal, plant or animal cells. Either constitutive, induced, or 
regulated promoters can be used in the present invention. 
Promoters suitable for use in eukaryotic host cells are well 
known to those of skill in the art and are described elsewhere 
in the specification. 
0105 Additional HopU1 substrates may be isolated or 
identified from any suitable source, for example, from 
genomic or cDNA libraries, plant extracts, or plant or animal 
cells. Extracts may be from any plant, dicot or monocot, 
Such as rice, wheat, corn, tomato, corn, soybean, Sunflower, 
Sorghum, canola, alfalfa, cotton, barley or millet. Extracts 
may be from any plant, insect, yeast, or mammalian cells. 
Examples of mammalian cells also include those cells that 
grow in cell culture, such as HeLa, 22RV1 (human prostatic 
cells), and 293T cells and the like. In one aspect, HopU1 
substrates may be identified either in vivo or in vitro using 
any number of methods. 
0106 Functional assays for ADP-ribosyltransferase can 
be conducted by incubating the HopU1 polypeptide with a 
candidate HopU1 Substrate or an extract Suspected of con 
taining a HopU1 Substrate (see Example 7)), in the presence 
of NAD" or an analog labeled with a radioisotope such as 
P. biotin, or a fluorescent group. (Sun, J., and J. T. Barbieri. 
Pseudomonas aeruginosa ExoT ADP-ribosylates CT 10 
regulator of kinase (Crk) proteins. J. Biol. Chem. 
278:32794-32800 (2003)). Substrates that contain the bioti 
nylated NAD+ may be isolated and concentrated with avidin 
affinity chromatography and identified. (Zhang, J. Use of 
biotinylated NAD to label and purify ADP-ribosylated pro 
teins. Methods Enzymol. 280:255-265 (1997); and Zhang, 
J., and S. H. Snyder. Purification of a nitric oxide-stimulated 
ADP-ribosylated protein using biotinylated beta-nicotina 
mide adenine dinucleotide. Biochem. 32:2228-2233 
(1993)). 
0.107 ADP-ribosylation can be monitored by incorpora 
tion of the label into the protein phase, by a change of size 
of the target protein (measurable, for example on a protein 
gel), or by detection of ADP ribose polymers on the target 
(for example, using commercially available antibody spe 
cific for ADP-ribose polymers, or by physical-chemical 
mechanisms, such as mass spectrometry). Known ADP-RT 
inhibitors like novobiocin can be used to verify the speci 
ficity of the assay. Polypeptides with confirmed ADP-RT 
ribosylation can then be used in methods of the present 
invention, for example, enhancing the innate immune sys 
tem of a plant or further characterized. For example, two 
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dimensional PAGE may be performed on ADP-RT reactions 
and detected for example by autoradiology. Radiolabled 
spots may be isolated from the gel and digested with 
enzymes Such as endopeptidases and analyzed with tandem 
mass spectrometry to identify the HopU1 substrate. The 
cDNAs of the identified HopU1 substrates may be isolated 
or amplified from the plant or animal nucleic acids, a nucleic 
acid library, or produced by synthetic chemistry. The poly 
nucleotide sequence of the HopU1 substrate may be inserted 
into any of the many available expression vectors and cell 
systems using reagents that are well known in the art. For 
example, HopU1 Substrate sequences may be ligated into a 
GST fusion vector, transformed in bacteria and purified with 
glutathione Sepharose and subjected to in vitro ADP-RT 
assays with HopU1, for example, HopU1 His as described in 
Example 3. Two-dimensional PAGE and autoradiology be 
performed on the reactions to determine whether the candi 
date HopU1 substrates were ADP-ribosylated by HopU1 in 
vitro. 
0108. In one aspect, mammalian substrates of HopU1 
may be identified using any of methods described herein or 
known to one skilled in the art. For example, extracts from 
mammalian cells may be added to an ADP-RT reaction mix 
containing HopU1, for example, HopU1 His or HopU1 
His and then the samples separated, using for example, a 
SDS-PAGE. Ribosylation may be detected as described 
herein, including exposing ADP-RT reactions separated by 
SDS-PAGE to film where protein bands may be detected and 
further analyzed. (See FIG. 14 which shows a protein band 
of about 29 kDa that was ADP-ribosylated in a HopU1 
dependent manner. The molecular mass of this ADP-ribo 
sylated protein is similar to several of the substrates that 
were ADP-ribosylated in plant extracts by HopU1. Mam 
malian substrates of HopU1 may be identified in vitro and in 
Vivo experiments, using for example, heterologous delivery 
of HopU1 into animal cells via the P. aeruginosa TTSS. In 
another aspect, the method includes localizing HopU1 and 
its substrates to determine if they co-localize. The Barbieri 
protocol may be used for preparing the cell line extracts, 
which includes an acetone precipitation step. 1. Sun, J., and 
J. T. Barbieri. 2003. Pseudomonas aeruginosa ExoT ADP 
ribosylates CT10 regulator of kinase (Crk) proteins. J. Biol. 
Chem. 278:32794-32800. P-NAD ART (ADP-ribosyl 
transferase) assays may be performed as described herein 
above and subjected to 2D SDS-PAGE and autoradiography. 
Protein spots that align with ADP-RT activity spots may be 
identified using MALDI-TOF and Q-TOF MS. Mammalian 
HopU1 substrates include but are not limited to RNA 
binding proteins. 
0109. In another aspect, the HopU1 substrates are sub 
strates of HopU1 identified in planta. The ADP-ribosylation 
of substrates by HopU1 can be determined using transient 
expression in a plant, for example, in Nicotiana benthami 
ana using binary vectors that express a HopU1 polypeptide 
and a HopU1 substrate or a candidate HopU1 substrate. The 
HopU1 polypeptide and HopU1 substrate or a candidate 
HopU1 substrate may contain epitopes for detection by 
antibodies as necessary, for example, HA, FLAG, HopU1, 
GRP-RBP or CP-RBP antibodies. Extracts from the tran 
siently expressed plant may be analyzed by using a combi 
nation of SDS-PAGE gels and immunoblots using antibod 
ies that recognize the HopU1 polypeptide and HopU1 
substrate or a candidate HopU1 substrate, for example, HA, 
FLAG, HopU1, GRP-RBP or CP-RBP antibodies. If a 
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substrate is ADP-ribosylated by HopU1, the substrate's 
molecular mass would be expected to increase by 541 Da 
increments (the molecular mass of ADP-ribose) as indicated 
by a shift in mobility. 
0110. In another aspect, the HopU1 substrates are sub 
strates of HopU1 identified in vivo. In one aspect, P 
labeled NAD+ is introduced into plant suspension or mam 
malian cultured cells that express HopU1 and then extracts 
from these cells are analyzed with SDS-PAGE and autora 
diography. (Sun, J., and J. T. Barbieri. Pseudomonas aerugi 
nosa ExoT ADP-ribosylates CT10 regulator of kinase (Crk) 
proteins. J. Biol. Chem. 278:32794-32800 (2003)). Protein 
spots that co-migrate with the Plabeled proteins may be 
identified using mass spectrometry. 
0111. In one aspect, a polypeptide, variant or fragment of 
the HopU1 substrate may be over-expressed in a plant. The 
HopU1 substrate that is to be over-expressed may be 
mutated in its amino acid residues that are suspected or 
known to be ribosylated by HopU1 so that the HopU1 
substrate is notable to be modified by HopU1. For example, 
the number of amino acid residues that are ADP-ribosylated 
may be determined using mass spectrometry. HopU1 Sub 
strate polynucleotides or candidate HopU1 substrate poly 
nucleotides may be cloned into a vector that fuses the 
Substrate to an affinity tag so that it can be partially purified, 
subjected to ADP-RT reactions, SDS-PAGE, and liquid 
chromatography coupled with tandem mass spectrometry to 
determine the mass difference between a modified or 
unmodified substrate. The peptides may be analyzed with 
ESI-MS-MS to identify the residues that are ADP-ribosy 
lated. The amino acid or amino acids that is/are modified 
within the substrate may be altered with site-directed 
mutagenesis, purified with affinity chromatography and 
retested in ADP-RT assays to confirm that the modified 
HopU1 substrate is no longer ADP-ribosylated by HopU1. 
The modified HopU1 substrate lacking residues that are 
ADP-ribosylated by HopU1 may be introduced into a plant 
either transiently or transgenically and over-expressed into a 
plant to enhance the innate immune response. 
0112 Enhancement of the plants innate immune 
response may be achieved through over-expression of one or 
more HopU1 substrates. As discussed above, one of skill 
will recognize the appropriate expression vector and pro 
moter to use to express the HopU1 substrate. Exemplary 
promoters for this embodiment include constitutive promot 
ers or promoters that are preferentially active in all or most 
plant tissues including, for example, those active in tissues 
of leaves, stems and roots. 
0113 Leaf-preferred and stem-preferred promoters are 
known in the art. See, for example, Yamamoto et al. (1997) 
Plant J. 12(2):255-265; Kwon et al. (1995) Plant Physiol. 
105:357-67: Yamamoto et al. (1995) Plant Cell Physiol. 
35(5):773-778; Gotor et al. (1993) Plant J. 3:509-18: 
Orozco et al. (1993) Plant Mol. Biol. 23(6):1129-1138; 
Baszczynski et al. (1988) Nucl. Acid Res. 16:5732; Mitra et 
al. (1995) Plant Molecular Biology 26:35-93; Kayaya et al. 
(1995) Molecular and General Genetics 258:668-675; and 
Matsuoka et al. (1993) Proc. Natl. Acad. Sci. USA 
90(20):9586-9590. Senescence regulated promoters are also 
of use, such as, SAM22 (Crowell et al. (1992) Plant Mol. 
Biol. 18:559-566). See also U.S. Pat. No. 5,589,052, herein 
incorporated by reference. 
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0114 Root-preferred promoters are known and can be 
selected from the many available from the literature or 
isolated de novo from various compatible species. See, for 
example, Hire et al. (1992) Plant Mol. Biol. 20(2):207-218 (Soybean root-specific glutamine synthetase gene); Keller 
and Baumgartner (1991) Plant Cell 3(10): 1051-1061 (root 
specific control element in the GRP 1.8 gene of French 
bean); Sanger et al. (1990) Plant Mol. Biol. 15(3):533-553 (root-specific promoter of the mannopine synthase (MAS) 
gene of Agrobacterium tumefaciens); and Miao et al. (1991) 
Plant Cell 3(1): 11-22 (full-length cDNA clone encoding 
cytosolic glutamine synthetase (GS), which is expressed in 
roots and root nodules of soybean). 
0115 Exemplary transfection or transformation tech 
niques to achieve over-expression are described elsewhere 
in the specification. Modulation of HopU1 substrate expres 
sion in a plant or plant cell provides a novel strategy for 
enhancing the innate immune system of a plant exposed to 
a biotic stress. The evaluation of the effect of HopU1 
Substrate over-expression on the plants innate immune 
response to a biotic stress may also include evaluation of 
phenotypic changes. As described in Example 2, plants may 
be treated with bacterial flagellin flg22 as a biotic stress to 
trigger the innate immune response. Examples of phenotypic 
changes to a biotic stress include but are not limited to 
maintained or increased callose deposition, elicitation of the 
HR, oxidative burst (ROS levels), phenolic accumulation, 
and decreased pathogen multiplication or disease symptoms 
of the pathogen. In one aspect, the phenotypic changes are 
measured as compared to a control that does not have 
over-expression of the HopU1 substrate. In one aspect, the 
phenotypic changes are measured as compared to a control 
that over-expresses both HopU1 and the HopU1 substrate. 
EXAMPLES 
Example 1 
hop U1 Encodes a Putative ADP-RT 
0116) To begin to characterize the DC3000 effector genes 
that potentially encode ADP-RTs we focused on hopU1, 
which is downstream of an apparent type III promoter and 
the shclf type III chaperone gene and the hopF2 effector gene 
in the DC3000 chromosome (FIG. 1b). Semi-quantitative 
RT-PCR experiments indicated the hopU1 gene is tran 
scribed and its expression was elevated when DC3000 was 
grown in a medium that induces the expression of the T3SS 
(FIG. 1c). Three regions of HopU1 share similarity with 
known ADP-RTS (FIG. 1a). HopU1 was type III-injected 
into plant cells based on adenylate cyclase translocation 
assays (FIG. 11a). A DC3000 AhopU1 mutant was reduced 
6 fold in its ability to multiply in plant tissue and cause 
disease symptoms in A. thaliana Col-0 (FIG. 11b). 
Example 2 
HopU1 Suppresses Plant Innate Immunity 
0117 We earlier reported that DC3000 mutants defective 
in type III effectors that can Suppress the hyperSensitive 
response (HR), a programmed cell death of plant cells 
associated with innate immunity, often display an enhanced 
ability to elicit an HR (Jamir, Y. et al. Identification of 
Pseudomonas Syringae type III effectors that Suppress pro 
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grammed cell death in plants and yeast. Plant J. 37:554-565 
(2004)). To investigate whether the AhopU1 mutant shared 
this phenotype we infiltrated wild type DC3000 and the 
AhopU1 mutant at different cell densities into Nicotiana 
tabacum cv. Xanthi (tobacco). We consistently found that 
the AhopU1 mutant elicited an HR in tobacco at cell 
densities below the threshold needed for wild type DC3000 
(FIG. 2a). When hopU1 was expressed in trans in the 
AhopU1 mutant it complemented this phenotype (FIG. 2a). 
We also assessed cell death by measuring the amount of ion 
leakage from plant cells and found that the AhopU1 mutant 
caused more cell death than DC3000 and expression of 
hopU1 in trans reduced the amount of cell death to wild type 
levels (FIG. 11a). Taken together, these results provide 
genetic evidence that HopU1 acts as a Suppressor of the 
nonhost HR. 
0118. To determine whether the predicted ADP-RT activ 
ity of HopU1 was required for suppression of the HR, we 
ectopically expressed in the AhopU1 mutant a HopU1 
derivative (HOPU 1) that had its glutamic acid residues in 
its putative ADP-RT active site (FIG. 1a) substituted with 
aspartic acids. This strain elicited an enhanced HR similar to 
the AhopU1 mutant control Suggesting that the Suppression 
of the HR required a functional ADP-RT active site (FIG. 
2b). Ion leakage conductivity assays indicated that the 
AhopU1 mutant expressing HopU1 caused similar 
amounts of cell death as the AhopU1 mutant control (FIG. 
12b). Thus, the HR suppression activity of HopU1 requires 
a functional ADP-RT catalytic site. 
0119 We reasoned that HopU1 may be capable of Sup 
pressing other innate immune responses. To test this we 
generated transgenic A. thaliana Col-O plants that constitu 
tively produced HopU1 fused to a hemagglutinin epitope 
(HopU1-HA). Bacterial flagellin often acts as a pathogen 
associated molecular pattern (PAMP), a conserved molecule 
from a microorganism recognized by animal and plant 
innate immune systems (Numberger, T., Brunner, F. Kem 
merling, B. & Piater, L. Innate immunity in plants and: 
striking similarities and obvious differences. Immunol. Rev. 
198:249-266 (2004); Akira, S., Uematsu, S. & Takeuchi, O. 
Pathogen recognition and innate immunity. Cell 124:783 
801 (2006); and Jones, J. D. & Dangl, J. L. The plant 
immune system. Nature 444:323-329 (2006)). A conserved 
peptide from bacterial flagellin, flg22, has been shown to be 
effective at triggering callose (B-1-3 glucan) deposition 
(Gomez-Gomez, L., Felix, G. & Boller, T. A single locus 
determines sensitivity to bacterial flagellin in Arabidopsis 
thaliana. Plant J. 18:277-284 (1999)). The HopU1-HA 
expressing transgenic plants treated with flg22 produced 
significantly reduced amounts of callose compared to wild 
type plants (FIGS. 2c and d). These plants also elicited a 
delayed atypical HR in response to the type III effector 
AvrRpt2, which is recognized by the RPS2 resistance pro 
tein present in A. thaliana Col-0 (Whalen, M. C., Innes, R. 
W., Bent, A. F. & Staskawicz, B. J. Identification of 
Pseudomonas Syringae pathogens of Arabidopsis and a 
bacterial locus determining avirulence on both Arabidopsis 
and soybean. Plant Cell 3:49-59 (1991)) (FIG. 13). Together 
these data indicate that HopU1 can Suppress innate immune 
responses that are triggered by both a type III effector 
protein or a PAMP. 
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Example 3 
HopU1 is an Active ADP-RT 
0120) To explore whether HopU1 indeed possessed ADP 
RT activity we purified recombinant HopU1 and the cata 
lytic site mutant (HOPU1), both fused to histidine affinity 
tags (FIG.3a). The activity of recombinant HopU1-His was 
tested with poly-L-arginine, an artificial Substrate for many 
ADP-RTs that can modify arginine residues. HopU1-His 
was capable of ADP-ribosylating poly-arginine in the pres 
ence of P-NAD, while the HopU1-His mutant incor 
porated radioactivity in amounts similar to the BSA control 
(FIG. 3b). Therefore, HopU1 is an active ADP-RT that can 
modify arginine residues. 
0121 We next examined whether HopU1-His was 
capable of using plant proteins as Substrates. Crude protein 
extracts from the leaves of A. thaliana ecotype Col-0 and 
tobacco were used in ADP-RT reactions. ADP-RT reactions 
were separated by SDS-PAGE, and subjected to autoradiog 
raphy (FIG. 3c). At least two proteins in A. thaliana extracts 
and three in tobacco were ADP-ribosylated by HopU1-His. 
No labelled products were detected from reactions using the 
inactive HopU1-His (FIG. 3c). Therefore, HopU1-His 
can use several Arabidopsis and tobacco proteins as Sub 
Strates. 
Example 4 
RNA-Binding Proteins are Substrates 
0122) To determine the identity of the proteins ADP 
ribosylated by HopU1 in A. thaliana extracts we separated 
ADP-RT reactions with two-dimensional (2D) PAGE fol 
lowed by autoradiography (for representative examples, see 
FIG. 14). One well separated protein spot stained with 
Coomassie blue has the identical migration as a radiola 
belled ADP-RT activity spot. It was analyzed with tandem 
mass spectrometry and corresponded to chloroplast RNA 
binding protein (CP-RBP) AtRBP31 (Ohta, M., Sugita, M. 
& Sugiura, M. Three types of nuclear genes encoding 
chloroplast RNA-binding proteins (cp29, cp31 and cp33) are 
present in Arabidopsis thaliana: presence of cp31 in chlo 
roplasts and its homologue in nuclei/cytoplasms. Plant Mol. 
Biol. 27:529-539 (1995)) (Table 1). The other ADP-RT 
activity spots did not co-migrate with visible Coomassie 
blue-stained protein spots suggesting that these proteins 
were in lower abundance. To enrich for less abundant 
Substrates more concentrated A. thaliana extracts were made 
and fractionated using ion exchange chromatography. ADP 
RT assays were performed on aliquots of each fraction (FIG. 
9b). Coomassie blue-stained protein spots that had identical 
migration patterns as ADP-RT modified protein spots visible 
on autoradiograms were analyzed with tandem mass spec 
trometry. In total, we found three CP-RBPs and two glycine 
rich RNA-binding proteins (GR-RBPs), AtGRP7 and 
AtGRP8, to be ADP-ribosylated by HopU1-His (Table 1). 
0123 To confirm that the identified CP-RBPs and GR 
RBPs were substrates for HopU1-His, we constructed glu 
tathione S-transferase (GST) fusions. Substrate-GST fusions 
were partially purified with glutathione Sepharose or used as 
crude lysates in ADP-RT reactions. Each of the substrate 
GST fusions could act as substrates for HopU1-His (FIG. 
4a). Other plant protein-GST fusion corresponding to pro 
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teins neighbouring HopU1 Substrates on 2D polyacrylamide 
gels were not ADP-ribosylated by HopU1-His. Thus, these 
CP-RBPs and GR-RBPs indeed are in vitro Substrates for the 
HopU1 ADP-RT. We did not find additional HopU1 sub 
strates in our extensive mass spectrometry analyses Suggest 
ing that the in vivo targets of HopU1 are among these 
proteins. 
0.124 CP-RBPs and GR-RBPs belong to a group of 
RNA-binding proteins that all have in common an RNA 
recognition motif (RRM), a protein domain demonstrated to 
be necessary and sufficient for RNA binding (Burd, C. G. & 
Dreyfuss, G. Conserved structures and diversity of functions 
of RNA-binding proteins. Science 265:615-621 (1994); and 
Jessen, T. H., Oubridge, C., Teo, C.-H., Pritchard, C. & 
Nagai, K. Identification of molecular contacts between the 
U1 A small nuclear ribonucleoprotein and U1 RNA. EMBO 
10:3447-3456 (1991)). Localization experiments found that 
HopU1-GFP (and HopU1-GUS) and the GR-RBPs AtGRP7 
and AtGRP8 GFP fusion proteins were similarly localized to 
the cytoplasm and possibly to the nucleus, while the CP 
RBP-GFP fusions were discretely localized to the chloro 
plast (FIG. 10). Because of our localization experiments and 
the association of GR-RBPs with abiotic and biotic stress 
(Gomez, J. et al. A gene induced by the plant hormone 
abscisic acid in response to water stress encodes a glycine 
rich protein. Nature 334:262-264 (1988); and Naqvi, S. M. 
et al. A glycine-rich RNA-binding protein gene is differen 
tially expressed during acute hyperSensitive response fol 
lowing Tobacco Mosaic Virus infection in tobacco. Plant 
Mol. Biol. 37:571-576 (1998)), we focused on the GR-RBPs 
as putative physiological targets of HopU1. 
0.125) The GR-RBP AtGRP7 and AtGRP8 are homolo 
gous to each other sharing 76.9% identity and likely perform 
related functions. AtGRP7 has been shown to bind RNA and 
influence mRNA oscillations in response to circadian 
rhythms at the post-transcriptional level (Heintzen, C., 
Nater, M., Apel, K. & Staiger, D. AtGRP7, a nuclear 
RNA-binding protein as a component of a circadian-regu 
lated negative feedback loop in Arabidopsis thaliana. Proc. 
Natl. Acad. Sci. USA 94:8515-8520 (1997); and Staiger, D., 
Zecca, L., Wieczorek Kirk, D. A., Apel, K. & Eckstein, L. 
The circadian clock regulated RNA-binding protein 
AtGRP7 autoregulates its expression by influencing alter 
native splicing of its own pre-mRNA. Plant J. 33:361-371 
(2003)). AtGRP7 contains 14 arginine residues that repre 
sent putative sites of ADP-ribosylation (FIG. 4b). We found 
that the RRM domain-GST fusion was ADP-ribosylated by 
HopU1-His, while the glycine-rich domain-GST fusion was 
not (FIG. 4c). To determine the arginine residues required 
for ADP-ribosylation, each arginine of RRM was individu 
ally mutated to lysine in full length AtGRP7-GST fusions. 
When arginines in positions 47 or 49 of AtGRP7 were 
substituted with lysine these AtGRP7-GST derivatives were 
no longer ADP-ribosylated Suggesting that one of these 
residues is the site of the ADP-ribose modification while the 
other may be required for substrate recognition (FIG. 4c). 
Interestingly, based on the RRM domain structure in other 
RNA-binding proteins both of these residues would likely be 
solvent-exposed (Maris, C., Dominguez, C. & Allain, F. H. 
The RNA recognition motif, a plastic RNA-binding platform 
to regulate post-transcriptional gene expression. FEBS J. 
272:21 18-2131 (2005)). Moreover, the arginine in position 
49 is within RNP1, the most conserved region of the RRM 
domain and one that has been directly implicated in RNA 
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binding Burd, C. G. & Dreyfuss, G. Conserved structures 
and diversity of functions of RNA-binding proteins. Science 
265, 615-621 (1994)). 
0126 To determine if AtGRP7 can be ADP-ribosylated 
by HopU1 in planta, we co-expressed HopU1-FLAG or 
HopU1-FLAG and AtGRP7-HA or AtGRP7R-HA (an 
AtGRP7 derivative that cannot be ADP-ribosylated) in N. 
benthamiana using Agrobacterium transient assays. After 40 
h, plant extracts isolated from leaf tissue were separated on 
SDS-PAGE gels and analyzed with immunoblots using 
anti-FLAG or anti-HA antibodies. We consistently observed 
an increase in the molecular mass of AtGRP7-HA when it 
was expressed in planta with HopU1-FLAG, but not when 
expressed with HopU1-FLAG or when HopU1-FLAG 
was expressed with AtGRP7R-HA (FIG. 4d) suggesting 
that the increased molecular mass was due to ADP-ribosy 
lation. Therefore, HopU1-FLAG can ADP-ribosylate 
AtGRP7-HA inside the plant cell. 
Example 5 
A Atgrp7 Mutant is More Susceptible 
0127. To determine the involvement of AtGRP7 in plant 
innate immunity we identified an A. thaliana SALK 
homozygous T-DNA insertion line (Alonso, J. M. et al. 
Genome-wide insertional mutagenesis of Arabidopsis 
thaliana. Science 301, 653-657 (2003)) in the AtGRP7 
locus, and confirmed that it did not produce AtGRP7 mRNA 
and protein (FIG. 11). To determine if this mutant, desig 
nated Atgrp7-1, was altered in its responses to P. syringae, 
we infected wild type A. thaliana Col-0 and the Atgrp7-1 
mutant plants with DC3000 and a AhrcC mutant defective in 
the T3SS. DC3000 caused enhanced disease symptoms on 
Atgrp7-1 mutant plants compared to wild type Col-0 (FIG. 
5a). Each strain grew to higher levels in Atgrp7-1 plants 
compared to wild type Col-O plants (FIG.5b), indicating that 
Atgrp7-1 plants were more susceptible to P. syringae. The 
growth difference was even more pronounced for the AhrcC 
mutant, which is likely due to the fact that this strain cannot 
inject any type III effectors, many of which Suppress innate 
immunity. Importantly, we found that flig22-induced callose 
deposition was reduced in Atgrp7-1 plants compared to wild 
type A. thaliana Col-0 (FIG. 5c), further supporting that 
Atgrp7-1 mutant plants were impaired in their innate 
immune responses. Similar phenotypes were observed for an 
independent T-DNA mutant designated Atgrp7-2 (FIG. 12). 
Example 6 
Discussion 
0128 Several plant pathogen type III effectors are known 
to suppress outputs of innate immunity (Abramovitch, R. B., 
Anderson, J. C. & Martin, G. B. Bacterial elicitation and 
evasion of plant innate immunity. Nat. Rev. Mol. Cell. Biol. 
7:601-611 (2006)). However, the enzymatic activity and 
substrates for these type III effectors remain poorly under 
stood (Grant, S. R. Fisher, E. J., Chang, J. H., Mole, B. M. 
& Dangl, J. L. Subterfuge and Manipulation: Type III 
Effector Proteins of Phytopathogenic Bacteria. Annu Rev 
Microbiol 60:425-449 (2006)). Indeed, there are only two 
cases that both an enzymatic activity and a Substrate for a 
plant pathogen type III effector are known (Axtell, M. J. & 
Staskawicz, B. J. Initiation of RPS2-specified disease resis 
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tance in Arabidopsis is coupled to the AvrRpt2-directed 
elimination of RIN4. Cell 112:369-377 (2003); Mackey, D., 
Belkhadir, Y. Alonso, J. M., Ecker, J. R. & Dangl, J. L. 
Arabidopsis RIN4 is a target of the type III virulence effector 
AvrRpt2 and modulates RPS2-mediated resistance. Cell 
112:379-389 (2003); and Shao, F. et al. Cleavage of Arabi 
dopsis PBS1 by a bacterial type III effector. Science 
301:1230-1233 (2003)). The substrates of the HopU1 ADP 
RT suggest a novel strategy utilized by bacterial pathogens 
to modulate plant innate immunity by indirectly affecting 
host RNA status. That is, GR-RBPs may act as key post 
transcriptional regulators through either the trafficking, sta 
bilization, or processing of specific mRNAS in response to 
pathogen stress and the ADP-ribosylation of the GR-RBPs 
by HopU1 may disrupt their activity (FIG. 13). By disabling 
the function of GR-RBPs the pathogen may reduce the 
amount of immunity-related mRNAs available in the plant 
and tip the balance of the interaction in favor of the 
pathogen. 
0129. To our knowledge, this is the first demonstration of 
an active ADP-RT virulence protein in a plant pathogen. The 
DC3000 genome encodes at least two additional putative 
ADP-RTs, HopO1-1 and HopO1-2. These ADP-RTs possess 
low similarity with HopU1 and, therefore, likely target other 
plant proteins. ADP-RTs are well characterized in animal 
pathogens. However, the ADP-RT substrates described here 
are novel. Interestingly, IpaH9.8, a type III effector from the 
animal pathogen Shigella flexneri was recently shown to 
bind the RRM-containing mammalian splicing factor U2AF 
(Maris, C., Dominguez, C. & Allain, F. H. The RNA 
recognition motif, a plastic RNA-binding platform to regu 
late post-transcriptional gene expression. FEBS J. 272:21 18 
2131 (2005)) resulting in the suppression of pro-inflamma 
tory cytokines (Okuda, J. et al. Shigella effector IpaH9.8 
binds to a splicing factor U2AF(35) to modulate host 
immune responses. Biochem. Biophys. Res. Commun. 
333:531-539 (2005)). The enzymatic activity of IpaH9.8 is 
presently unknown. The protein targets of HopU1 and 
IpaH9.8 Suggest that animal and plant pathogens may alter 
RNA metabolism to quell the eukaryotic immune response. 
Example 7 
Methods Summary 
0.130 Bacterial strains (and plasmids) and primers used 
in this work are listed in Tables 2 and 3, respectively. A 
AhopU1 mutant was made by homologous recombination. 
Expression of hopU1 was assessed with RT-PCR (Guo, M. 
et al. Pseudomonas Syringae type III chaperones ShcO1, 
ShcS1, and ShcS2 facilitate translocation of their cognate 
effectors and can substitute for each other in the secretion of 
HopO1-1. J. Bacteriol. 187:4257-4269 (2005)). Construc 
tion of A. thaliana Col-0 transgenic plants was done using 
the Agrobacterium-mediated floral dip method (Bechtold, 
N., Ellis, J. & Pelletier, G. In planta Agrobacterium mediated 
gene transfer by infiltration of adult Arabidopsis thaliana 
plants. C. R. Acad. Sci. Ser: III Sci. Paris 3.16:1194-1199 
(1993)). DC3000 strains were tested for their ability to elicit 
an HR on Nicotiana tabacum cv. Xanthi by infiltrating 
strains resuspended in 5 mMMES (pH 5.6) at a cell density 
of 1x10° or 1x10" cells/ml. Pathogenicity assays with A. 
thaliana plants were performed by spray-inoculation with 
bacterial Suspensions (Espinosa, A., Guo, M., Tam, V.C., 
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Fu, Z. Q. & Alfano, J. R. The Pseudomonas Syringae type 
III-secreted protein HopPtol 2 possesses protein tyrosine 
phosphatase activity and Suppresses programmed cell death 
in plants. Mol. Microbiol. 49:377-387 (2003)). Seeds of the 
Arabidopsis SALK 039556.21.25.x and SALK 
051743.42.85.x lines, corresponding to the Atgrp7-1 and 
Atgrp7-2 mutants, respectively, were obtained from the 
Arabidopsis Biological Resource Center at Ohio State Uni 
versity. A. thaliana plants were infiltrated with 1 uM offlg22 
and stained with aniline blue for callose as described 
(Gomez-Gomez, L., Felix, G. & Boller, T. A single locus 
determines sensitivity to bacterial flagellin in Arabidopsis 
thaliana. Plant J. 18:277-284 (1999)). Leaves were exam 
ined with a Zeiss AXioPlan2 Imaging System microscope 
with fluorescence. The poly-L-arginine assay was done as 
previously described (Coye. L. H. & Collins, C. M. Identi 
fication of Spy A, a novel ADP-ribosyltransferase of Strep 
tococcus pyogenes. Mol. Microbiol. 54:89-98 (2004)). The 
ADP-RT assay was adapted from a described protocol (Sun, 
J. & Barbieri, J. T. Pseudomonas aeruginosa ExoT ADP 
ribosylates CT10 regulator of kinase (Crk) proteins. J. Biol. 
Chem. 278:32794-32800 (2003)0. AtGRP7-GST site-di 
rected mutant constructs were made using the QuikChange 
Site-Directed Mutagenesis kit (Stratagene). In planta HopU1 
ADP-RT assays with AtGRP7 were done using Agrobacte 
rium delivery as described (Jamir, Y. et al. Identification of 
Pseudomonas Syringae type III effectors that Suppress pro 
grammed cell death in plants and yeast. Plant J. 37:554-565 
(2004)) and assessed with immunoblots. 
Methods 
Bacterial Strains and Nucleotide Primers. 
0131 Bacterial strains and plasmids used in this work are 
listed in Table 2. The primers used are listed in Table 3. 
Construction of the DC3000 AhopU1 Mutant. 
0132 A DC3000 AhopU1 mutant was made by amplify 
ing a 2 kb region upstream and downstream of hopU1 using 
PCR with primer sets P1058/P1059 and P1078/P1079. The 
DNA fragment upstream of hopU1 was ligated into pHP45C2 
using BamHI and HindIII sites. The DNA fragment down 
stream of hopU1 was ligated into the pHP45C2 derivative 
containing the upstream fragment using Xbal and SacI 
restriction enzymes such that the hopU1 flanking regions 
were on either side of an omega fragment in the same 
orientation. This cassette was ligated into the broad host 
range vector pRK415 using BamHI and SacI restriction 
enzymes. The resulting construct was electroporated into 
DC3000 and homologous recombination was selected for by 
selecting for retention of the antibiotic marker linked to the 
mutation, and loss of the plasmid marker. The resulting 
mutant, UNL141, was confirmed with PCR using primers 
that annealed to the flanking regions. 
RT-PCR to Determine hop U1 Expression. 
0133) The isolation of DC3000 RNA and reverse tran 
scriptase PCR were performed as in Guo et al. (Guo, M. et 
al. Pseudomonas syringae type III chaperones ShcO1, 
ShcS1, and ShcS2 facilitate translocation of their cognate 
effectors and can substitute for each other in the secretion of 
HopO1-1. J. Bacteriol. 187:4257-4269 (2005)). 
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Construction of A. thaliana Col-O Transgenic Plants 
Expressing HopU1-HA and HopU1-HA. 
0.134 hopU1 was amplified with PCR and recombined 
into the Gateway entry vector pENTR/D-TOPO. Site-di 
rected mutagenesis was carried out on this entry construct to 
change the two glutamic acids in the ADP-RT active site to 
aspartic acids using the QuikChange Site-Directed 
Mutagenesis kit (Stratagene). The resulting constructs were 
recombined into binary Gateway destination vectors such 
that the hopU1 derivatives were downstream of a CaMV 35S 
promoter, electroporated into Agrobacterium tumefaciens 
C58C1, and transformed into A. thaliana Col-0 using the 
Agrobacterium-mediated floral dip method (Bechtold, N., 
Ellis, J. & Pelletier, G. In planta Agrobacterium mediated 
gene transfer by infiltration of adult Arabidopsis thaliana 
plants. C. R. Acad. Sci. Ser. III Sci. Paris 3.16:1194-1199 
(1993)). Plants were propagated through four generations 
and confirmed to constitutively produce HopU1-HA or 
HopU1-HA with immunoblots using anti-HA antibodies. 
Plant Materials and Bioassays. 
0135 P. syringae pv. tomato DC3000 strains were tested 
for their ability to elicit an HR on Nicotiana tabacum cv. 
Xanthi by infiltrating strains resuspended in 5 mMMES (pH 
5.6) at a cell density of 1x10° or 1x107 cells/ml with a 
needleless syringe. The AhopU1 mutant UNL141 strain 
carrying plasmids pN1981 (encoding HopU1), pIN1982 
(encoding HOPU1), or pML 123 (empty vector) were 
used in HR Suppression experiments. Pathogenicity assays 
with A. thaliana Col-0 and Atgrp7 mutant plants were 
performed by spray-inoculation with bacterial Suspensions 
that were adjusted to an ODoo of 0.2 as described (Espinosa, 
A., Guo, M., Tam, V. C., Fu, Z. Q. & Alfano, J. R. The 
Pseudomonas syringae type III-secreted protein HopPtol)2 
possesses protein tyrosine phosphatase activity and Sup 
presses programmed cell death in plants. Mol. Microbiol. 
49:377-387 (2003)). Bacteria were enumerated from leaf 
tissue by plating dilutions on KB plates with the appropriate 
antibiotics. Seeds of Arabidopsis SALK lines SALK 
039556.21.25.x and SALK 051743.42.85.x, which were 
used to identify Atgrp7-1 and Atgrp7-2 mutants, respec 
tively, were obtained from the Ohio State University Bio 
logical Resource Center. Further description of methods 
used to confirm the homozygosity of the T-DNA inserts, and 
the absence of Atgrp7 RNA and AtGRP7 protein is in the 
Examples 8 and 9. 
Microscopic Detection of Callose Deposition. 
0.136 A. thaliana Col-0 wild type, Col-0 Atgrp7 mutant 
plants, and A. thaliana expressing HopU1-HA or HopU1 
HA were infiltrated with 1 M offlg22. After 16 h, the leaves 
were excised, cleared, and stained with aniline blue for 
callose as described (Gomez-Gomez, L., Felix, G. & Boller, 
T. A single locus determines sensitivity to bacterial flagellin 
in Arabidopsis thaliana. Plant J. 18:277-284 (1999)). 
Leaves were examined with a Zeiss AXioPlan2 Imaging 
System microscope with fluorescence. The number of cal 
lose depositions was determined with Quantity One software 
(Bio-Rad). Twenty fields of view (each 0.56 mm) were 
analyzed and averaged. The average and standard errors of 
three independent assays for each treatment were recorded. 
US 2008/0028487 A1 
Purification of HopU1-His and HopU1-His mutation 
derivative. 
0137 HopU1-His and HopU1-His mutation derivative 
were affinity-purified from E. coli BL21 (DE3) using Ni 
NTA resin following the manufacturers instructions (Qiagen). Purified HopU1-His and HopU1-His were 
stored in aliquots at -80° C. or on ice. HopU1-His and 
HopU1-His protein concentrations were measured with 
the BioRad Protein Assay Kit and the purity of the proteins 
was examined by SDS-PAGE. 
Poly-L-Arginine ADP-RT Assay. 
0138 To determine if HopU1 ADP-ribosylated the arti 
ficial Substrate poly-L-arginine we used a previously 
described protocol (Coye. L. H. & Collins, C. M. Identifi 
cation of Spy A, a novel ADP-ribosyltransferase of Strepto 
coccus pyogenes. Mol. Microbiol. 54:89-98 (2004)). Briefly, 
homo-poly-L-arginine (80 ul of 10 mg/ml in 0.1 M dimethyl 
glutaric acid buffer pH 7.0), 1 uMP-NAD (GE Health 
care) radiolabeled on the ribose moiety and 1 uM HopU1 
His or HopU1-His were incubated at room temperature 
for 1 h, suspended in 0.1 M phosphate buffer, centrifuged, 
and resuspended in 250 ul of 0.1 M HCl and 500 ul 0.1 M 
dimethyl glutaric acid buffer (pH 7.0). Incorporated radio 
activity was determined using liquid scintillation. BSA (1 
uM) was used as a control. 
ADP-RT Assays with Plant Extracts and Recombinant Sub 
Strates. 
0.139. The ADP-RT assay was adapted from a described 
protocol (Sun, J. & Barbieri, J. T. Pseudomonas aeruginosa 
ExoT ADP-ribosylates CT10 regulator of kinase (Crk) pro 
teins. J. Biol. Chem. 278:32794-32800 (2003)). Briefly, 
approximately 10 ng of partially-purified HopU1-His was 
incubated with 5 uCi of PI-NAD (1 Ci/umole) and A. 
thaliana Col-0 or tobacco (N. tabacum cv. Xanthi) extracts, 
E. coli extracts or 1-2 ug of partially purified recombinant 
substrates. The reaction was stopped by adding SDS sample 
buffer after incubation at room temperature for 1 h. Samples 
were subjected to one-dimensional or two-dimensional 
SDS-PAGE followed by autoradiography of dried gels. 
AtGRP7-GST Plasmids and Site-Directed Mutagenesis of 
AtGRP7-GST. 
0140. The nucleotides corresponding to the RRM domain 
and the glycine-rich domain of AtGRP7 were separately 
PCR-amplified using primer sets P2578/P2579 and P2580/ 
P2581, respectively, and ligated into the GST vector pGEX 
5X- 1. The resulting plasmids encoded an RRM domain 
GST fusion (pAtGRP7-RRM) and glycine-rich domain 
GST fusion (pAtGRP7-Gly). Several constructs encoding 
full length AtGRP7-GST fusions in which individual argi 
nine residues in the RRM domain were substituted with 
lysines were made using the QuikChange Site-Directed 
Mutagenesis (Stratagene). The primers used to introduce 
these mutations and the resulting plasmids are listed in 
Tables 2 and 3. These constructs were separately expressed 
in E. coli to make lysates that contained AtGRP7-GST 
derivatives, which were used in ADP-RT assays. 
In Planta HopU1 ADP-RT Assays with AtGRP7 using 
Agrobacterium Delivery. 
0141 Agrobacterium transient co-delivery of AtGRP7 
HA and hopU1-FLAG or AtGRP7-HA and hopU1-FLAG 
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DNA were done as described in Jamir et al (Jamir, Y. et al. 
Identification of Pseudomonas syringae type III effectors 
that Suppress programmed cell death in plants and yeast. 
Plant J. 37:554-565 (2004)). After 40 h, plant tissue was 
harvested with a No. 8 cork borer (12 mm diameter), ground 
in liquid nitrogen, and resuspended in SDS sample buffer. 
Samples were subjected to SDS-PAGE and immunoblot 
analysis using anti-FLAG or anti-HA antibodies to deter 
mine the molecular mass of AtGRP7 in the presence or 
absence of active HopU1-FLAG. 
Example 8 
Bacterial Strains, Media, and Nucleotide Primers 
0.142 Bacterial strains and plasmids used in this work are 
listed in Table 2. Escherichia coli strain DH5O. was used for 
general cloning and DNA manipulations and for Gateway 
technology manipulations E. coli strain DB3.1 was used. 
Pseudomonas syringae pv. tomato DC3000 was grown in 
King's B (KB) broth at 30° C. or hrp-inducing fructose 
minimal medium at 22°C. (King, E. O., Ward, M. K. & 
Raney, D. E. Two simple media for the demonstration of 
pyocyanin and fluorescein. J. Lab. Med. 22:301-307 (1954): 
and Huynh, T.V., Dahlbeck, D. & Staskawicz, B.J. Bacterial 
blight of Soybean: Regulation of a pathogen gene determin 
ing host cultivar specificity. Science 245:1374-1377 (1989)). 
E. coli and Agrobacterium tumefaciens C58C1 were grown 
in LB broth at 37° C. and 30° C., respectively. Antibiotics 
were used at the following concentrations (ug ml): 
rifampicin, 100; ampicillin, 100; gentamicin, 10; kanamy 
cin, 50; and spectinomycin 50. Oligonucleotide primers are 
listed in Table 3. 
Adenylate Cyclase Translocation Assays. 
0.143. The adenylate cyclase assay used was modified 
from Schechter et al. (Schechter, L. M., Roberts, K. A., 
Jamir, Y., Alfano, J. R. & Collmer, A. Pseudomonas syringae 
type III Secretion system targeting signals and novel effec 
tors studied with a Cya translocation reporter. J. Bacteriol. 
186:543-555 (2004)). Briefly, DC3000 and the DC3000 
AhrcC type III defective mutant carrying the appropriate 
constructs, were infiltrated into N. benthamiana leaves at an 
ODoo of 0.6 in 5 mM MES (pH 5.6) containing 100 uM 
IPTG. Plants were sampled 10 h after infiltration with a 0.8 
cm cork-borer. Leaf disks were ground in liquid nitrogen and 
resuspended in 300 ul 0.1M HC1. Protein concentrations 
were measured using the Bio-Rad protein assay (Bio-Rad) 
and cyclic AMP was quantified using the Correlate-EIA 
Direct cAMP Enzyme Immunoassay kit (Assay Designs) 
according to the manufacturers instructions. 
Plant Materials and Bioassays. 
0.144 Pathogenicity assays with A. thaliana Col-0 were 
performed by spray or dip inoculation with bacterial Sus 
pensions that were adjusted to an ODoo of 0.2 as described 
(Espinosa, A., Guo, M., Tam, V. C., Fu, Z. Q. & Alfano, J. 
R. The Pseudomonas syringae type III-Secreted protein 
HopPtol 2 possesses protein tyrosine phosphatase activity 
and Suppresses programmed cell death in plants. Mol. 
Microbiol. 49:377-387 (2003)). Bacteria were enumerated 
from leaf tissue by plating dilutions on KB plates with the 
appropriate antibiotics. A. thaliana Col-O plants expressing 
either HopU1-HA or the catalytic mutant HopU1-HA 
were infiltrated with DC3000 with or without avrRpt2 at 
1x10 cells/ml. After 20h, the plants were photographed and 
assessed for production of an HR. 
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Ion Leakage Conductivity Assays. 
0145 To determine the amount of ion leakage occurring 
in plant tissue challenged with DC3000 strains we followed 
a previously described protocol (Mackey, D., Holt, B. F., III, 
Wiig, A. & Dangl, J. L. RIN4 interacts with Pseudomonas 
syringae type III effector molecules and is required for 
RPM1-mediated resistance in Arabidopsis. Cell 108: 743 
754 (2002)). Briefly, tobacco (N. tabacum cv. Xanthi) was 
infiltrated with bacterial strains containing 1x10° or 1x107 
cells/ml. After 24 h, three 0.49 cm leaf discs were removed 
and floated on 10 ml of freshwater for 1 h. The conductivity 
of this water was determined with a conductivity meter. 
Plasmid Constructions and Site-Directed Mutagenesis of 
HopU1. 
0146 The hopU1 gene was amplified with primers P687 
and P688 and recombined into pENTR/D-TOPO Gateway 
entry vector (Invitrogen) resulting in construct plN308. The 
codons corresponding to the catalytic glutamic acid residues 
of HopU1 in pl N308 were replaced with aspartic acid 
codons using the QuikChange Site-Directed Mutagenesis 
Kit (Stratagene) with primers P605 and P606 resulting in 
construct plN742. The HopU1-CyaA and HopU1-CyaA 
constructs were made by recombining plNOs and pLN742, 
respectively, into the CyaA Gateway destination vector 
pCPP3234 using Gateway cloning technology (Invitrogen) 
to yield pLN919 and pLN920, respectively. 
Example 9 
0147 Two-dimensional gel analysis and ion-exchange 
fractionation of Arabidopsis extracts. Twenty-five g of 6 
week old Arabidopsis leaves were collected and ground with 
sand in 100 ml of 50 mM MOPS, 250 mM sucrose (pH 7.2) 
with 2 tablets of Complete Protease Inhibitor (Roche). The 
extract was centrifuged at 12,000 g for 20 m followed by 
ultracentrifugation at 100,000 g for 30 m. The supernatant 
was collected and loaded into a Pharmacia FPLC and passed 
through a 1 ml HiTrap Q XL anion exchange column (GE 
Healthcare). Forty-five 1 ml fractions were then eluted with 
a NaCl gradient ranging from 0 to 500 mM in 30 mMMOPS (pH 8.0). ADP-ribosylation assays with HopU1-His were 
carried out on aliquots of these fractions. 
0148 ADP-RT reactions containing either crude Arabi 
dopsis protein extracts or anion-exchange fractions were 
separated on two-dimensional PAGE gels. The reaction 
mixtures were precipitated by adding 85% acetone (final 
concentration, V/v) at -20° C. for at least 2 h. Precipitated 
proteins were suspended in isoelectric focusing buffer (8 M 
urea, 2 M thiourea, 2% CHAPS, 2% Triton X-100, and 50 
mM DTT). Two hundred lug of Arabidopsis extract were 
loaded onto 7 cm pH 4-7 ReadyStrip IPG strips (BioRad). 
After 12 h of active rehydration, proteins were focused using 
the following program: step 1, 250 V for 15 m; step 2, 8000 
V for 1 h (slow voltage ramping); step 3, 8000 V for 30,000 
V-h; and step 4, holding at 500 V. The strip was then run in 
the second dimension using SDS-PAGE and stained with 
Coomassie blue G-250. Protein spots that had identical 
migrations as ADP-RT activity spots were cut out and 
identified using tandem mass spectrometry as described 
(Rohila, J. S., Chen, M., Cerny, R. & Fromm, M. E. 
Improved tandem affinity purification tag and methods for 
isolation of protein heterocomplexes from plants. Plant J. 
38:172-181 (2004)). 
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HopU1-GUS. HopU1-GFP, and Substrate-GFP Fusion 
Localization in Plant Cells. 
0.149 Localization of HopU1 and HopU1 substrates were 
analyzed by transient expression of B-glucuronidase (GUS) 
or green fluorescent protein (GFP) fusion constructs. GUS 
fusions were made in pRI121 (Chen, P. Y., Wang, C. K., 
Soong, S. C. & To, K. Y. Complete sequence of the binary 
vector pBI121 and its application in cloning T-DNA inser 
tion from transgenic plants. Mol. Breeding. 11:287-293 
(2003)). High quality DNAs were coated on M-17 tungsten 
particles (Bio-Rad), and bombarded on epidermal layers of 
onion bulbs using the Biolistic PDS-1000/He System (Bio 
Rad). The epidermal cells were allowed to recover on MS 
plates at room temperature under constant light for 1 day. 
The epidermal layers were stained for GUS activity as 
described (Varagona, M. J., Schmidt, R. J. & Raikhel, N. V. 
Nuclear localization signal(s) required for nuclear targeting 
of the maize regulatory protein opaque-2. Plant Cell 4:1213 
1227 (1992)), and stained cells were observed using a 
brightfield microscope. HopU1 and HopU1 substrates were 
fused to GFP in pKFWG2 (Karimi, M., Inze, D. & Depicker, 
A. GATEWAY vectors for Agrobacterium-mediated plant 
transformation. Trends Plant Sci. 7:193-195 (2002)) using 
the Gateway System (Invitrogen). The fusion constructs 
were transformed into A. tumefaciens C58C1, infiltrated into 
N. benthamiana leaves, and observed with an Olympus 
FV500 confocal laser scanning system with an upright 
microscope. 
Characterization of SALK lines SALK 039556.21.25.x 
and SALK 051743.42.85.X. 
0150. Seeds of the SALK T-DNA knock-out line, 
SALK 039556.21.25.x and SALK 051743.42.85.X were 
ordered from Arabidopsis Biological Resource Center at 
Ohio State University. Total genomic DNA was prepared 
from 4-5 week old individual plants. The homozygosity was 
confirmed using PCR with genomic DNA from individual 
plants. For SALK 039556.21.25.x (Atgrp7-1), primer set 
P2012/P1947 was used to confirm the presence of the 
T-DNA insertion and primer set P2012/P2013 was used to 
amplify the wild type AtGRP7 gene. For SALK 
051743.42.85x (Atgrp7-2) primer set P2456/P2457 was 
used to amplify wild type AtGRP7 product and P1947/ 
P2457 was used to confirm the presence of the T-DNA 
insertion. To confirm that AtGRP7 RNA was not present in 
the Atgrp7 mutants, total RNA was prepared with Trizol 
reagent (Invitrogen) following the manufacturers instruc 
tions. cDNAs were amplified from total RNA using RT-PCR 
at 44°C. with the RETRscript kit (Ambion Inc.) following 
their instructions. The primer set P1932/P1929 was used to 
confirm the absence of AtGRP7 mRNA in the homozygous 
T-DNA Atgrp7-1 and Atgrp7-2 knock-out plants. We used 
previously described antibodies (Heintzen, C. et al. A light 
and temperature-entrained circadian clock controls expres 
sion of transcripts encoding nuclear proteins with homology 
to RNA-binding proteins in meristematic tissue. Plant J. 
5:799-813 (1994)) referred to here as anti-GRPs to confirm 
the Atgrp7 mutants lacked AtGRP7. 
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Example 10 
Tables 1-3 
0151) 
TABLE 1. 
RNA-binding proteins (RBPs) identified with mass spectrometry 
MS) to be ADP-ribosylated by HopUl-His 
pI and mass p and mass % of protein 
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TABLE 1-continued 
RNA-binding proteins (RBPs) identified with mass spectrometry 
MS) to be ADP-ribosylated by HopUl-His 
pI and mass p and mass % of protein 
ADP-RT Substrate (kDa) of (kD) of ART coverage by 
(Accession No.) protein activity spot MS peptides' 
AtGRP7 Glycine-rich 5.9, 16.9 5.2, 20 27 
RBP (At2g21660.1) 
AtGRP8 Glycine-rich 5.3, 16.6 5.2, 17 19 
RBP (Atag39260.1) 
ADP-RT Substrate (kDa) of (kD) of ART coverage by 
(Accession No.) protein activity spot MS peptides' "Substrates were isolated based on their identical migration as protein 
spots that possessed ADP-RT activity and identified with MS. 
cp29-like Chloroplast 4.8, 30.7 4.5, 25 49 Calculated isoelectric points and molecular masses of identified substrates 
RBP (At2g37220.1) were based on their predicted protein sequence. 
cp31-like Chloroplast 4.6, 31.8 4.S. 27 37 Estimated isoelectric points and molecular masses were based on the 
RBP (AtsgSO2SO.1 w - . . - migration of protein spots with ADP-RT activity. (Atsg .1) The percent of coverage of the identified protein from the databases with 
AtRBP31 Chloroplast 4.3, 35.7 4.3, 32 15 peptides identified from the samples analyzed with MS. 
RBP (Atag24770.1) 
0152) 
TABLE 2 
Bacterial strains and plasmids used in this study 
Primer 
set used 
Designation Characteristics in cloning Reference 
Strains 
A. tumefaciens 
C58C1 Disarmed strain for transformation, Rif Gm' Van Larebeke, N. et al. 
Large plasmid in 
Agrobacterium timefaciens 
essential for crown 
gall-inducing ability. 
Nature 252, 169-170 (1974) 
E. coi 
BL21(DE3) FompT gal dcm lonhsdSE (rem: an E. coli Nowagen 
B strain) with DE3, a , prophage carrying the T7 
RNA polymerase gene 
DB3.1 F. gyra462 endA A(Sr1-recA) mcrB mirr Invitrogen 
hsdS20OrE-mE-) SupE44 ara14 galK2 lacY1 proA2 
rpsL20 (Str.) xyl5- leu mtl1 
DHSC SupE44 AlacU169(p80laczAM15) hsdR17 recA1 Life 
endA1 gyraS6 thi-1 relA1, Nal' Technologies 
P.S. tomato 
DC3OOO Wild type; spontaneous Rif Cuppels, D. A. & Ainsworth, 
DC3000-hrcC DC3000AhrcC., secretion deficient mutant, 
RpCm. 
UNL141 DC3000 AhopU1 mutant, Rift Sp. 
T. Molecular and physiological 
characterization of 
Pseudomonas Syringae pv. 
tomato and 
Pseudomonas Syringae pv. 
maculicola strains that 
produce the phytotoxin 
coronatine. Appl. Environ. 
Microbiol. 61, 3530-3536 
(1995) 
Yuan, J. & He, S. Y. The 
Pseudomonas Syringae Hrp 
regulation and Secretion 
system controls the production 
and secretion of multiple 
extracellular proteins. 
J. Bacteriol. 178, 6399-6402 
(1996) 
This work 
US 2008/0028487 A1 
Designation 
pAtGRP7-Gly 
pAtGRP7 
RRM 
pAvrRpt2-600 
pBI121 
pCPP3234 
pCPP5040 
pENTR/D- 
TOPO 
pET21 (+) 
pGEX-5X-1 
pHP45S2 
pLN308 
pLN462 
pLN742 
pLN870 
pLN919 
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TABLE 2-continued 
Bacterial strains and plasmids used in this study 
Characteristics 
Plasmids 
pGEX-5X-1 derivative that encodes the glycine 
rich domain of AtGRP7 fused at its N terminus to 
GST, Apr 
pGEX-5X-1 derivative that encodes the RRM 
domain of AtGRP7 fused at its N terminus to 
GST, Apr 
pDSK600 derivative containing avrRpt2, Sp/Sm. 
Binary vector for Agrobacterium-mediated plant 
transformation. Contains 35S promoter and the 
GUS encoding uidA gene, Km' 
Gateway destination vector containing the 
adenylate cyclase (cyaA) gene for C-terminal 
fusions, Sp/Sm. 
pML123 derivative converted into a Gateway 
destination vector, Gm. 
Gateway system donor vector, Kim' 
C-terminal Hiss-tag expression vector, Ap' 
N-terminal GST-tag expression vector, Ap' 
Vector containing an Sp/Sm' omega fragment 
with transcriptional and translational terminators, 
Apr SpR/SmR 
Gateway binary vector with an N-terminal GFP 
gene for GFP fusions, Sp/Sm. 
pENTRD-TOPO derivative carrying hopU1, Km. 
Gateway destination binary vector for transient 
assays, Sp/Sm. 
pENTRD-TOPO derivative carrying hopU1, 
Kim R. 
pET21 (+) derivative carrying hopU1, Ap' 
pCPP3234 derivative obtained by recombination 
with plN308 carrying hopU1, Sp/Sm. 
Primer 
set used 
in cloning Reference 
P2580, 
P2581 
P2578, 
P2579 
P687, 
P688 
P605, 
P606 
P775, 
P1132 
This work 
This work 
Pirhonen, M. U. et al. 
Phenotypic expression of 
Pseudomonas Syringaeavr 
genes in E. coli is 
linked to the activities of 
the hrp-encoded secretion 
system. Mol Plant-Microbe 
Interact. 9, 252-260 (1996) 
Clontech 
Schechter, L. M., Roberts, 
K. A., Jamir, Y., Alfano, 
. R. & Collmer, A. 
Pseudomonas Syringae type 
II secretion system targeting 
signals and novel effectors 
studied with a Cya 
translocation reporter. 
. Bacteriol. 186, 543-555 
(2004) 
amir, Y. et al. 
dentification of 
Pseudomonas Syringae 
type III effectors that 
Suppress programmed cell 
death in plants and yeast. 
Plant J. 37,554-565 (2004) 
nvitrogen 
Fellay, R., Frey, J. & 
Krisch, H. Interposon 
mutagenesis of soil and 
water bacteria: a family of 
DNA fragments designed for 
in vitro insertional 
mutagenesis of Gram-negative 
bacteria. Gene 52, 147-154 
(1987) 
Karimi, M., Inze, D. & 
Depicker, A. GATEWAY 
vectors for Agrobacterium 
mediated plant transformation. 
Trends Plant Sci. 7, 
93-195 (2002) 
This work 
amir, Y. et al. 
dentification of 
Pseudomonas Syringae 
type III effectors that 
Suppress programmed cell 
death in plants and yeast. 
Plant J. 37,554-565 (2004) 
This work 
This work 
This work 
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Designation 
LN920 
LN987 
LN1072 
LN1395 
LN1492 
LN1904 
LN1905 
LN1981 
LN1982 
LN1985 
LN1992 
LN1995 
LN1998 
LN1999 
LN2094 
LN21.78 
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TABLE 2-continued 
Bacterial strains and plasmids used in this study 
Characteristics 
pCPP3234 derivative obtained by recombination 
with plN742 carrying hopU1, Sp/Sm. 
pET21 (+) derivative carrying a hopU1 
mutation, Ap' 
pLN462 derivative containing hopU1 made by 
recombination with plN308, Sp/Sm. 
pLN462 derivative containing hopU1 made by 
recombination with plN742, Sp/Sm. 
pK7FWG2 derivative containing hopU1 made by 
recombination with plN308, Sp/Sm. 
pGEX-5X-1 derivative carrying At2g37220.1 
cDNA, Ap. 
pGEX-5X-1 derivative carrying AtSg50250.1 
cDNA, Api 
pCPP5040 derivative obtained by recombination 
with plN308, Gm. 
pCPP5040 derivative obtained by recombination 
with plN742, Gm. 
pCPP3234 derivative encoding AvrPtol-CyaA, 
SpR/SmR 
pGEX-5X-1 derivative carrying Atag24770.1 
cDNA, Ap. 
pENTRD-TOPO derivative carrying 
At2g37220.1 cDNA, Km. 
pENTRD-TOPO derivative carrying 
At4g24770.1 cDNA, Km. 
pENTRD-TOPO derivative carrying 
At5g50250.1 cDNA, Km. 
pK7FWG2 derivative containing At2g37220.1 
cDNA made by recombination with plN1995, 
SpR SmR. 
pGEX-5X-1 derivative carrying Atag39260.1 
(AtGRP8) cDNA, Apt 
pGEX-5X-1 derivative carrying At2g21660.1 
(AtGRP7) cDNA, Api 
pENTRD-TOPO derivative carrying hopU1 with 
a C-terminal FLAG fusion, Km. 
pLN462 derivative containing hopU1 with a C 
erminal FLAG tag made by recombination with pLN2028, Spr/Smr 
pENTRD-TOPO derivative carrying 
At2g21660.1 (AtGRP7) cDNA, Km. 
pENTRD-TOPO derivative carrying 
AtAg39260.1 (AtGRP8) cDNA, Km. 
pK7FWG2 derivative containing At2g21660.1 
(AtGRP7) cDNA made by recombination with 
PLN2059, SpR/SmR 
pLN462 derivative containing At2g21660.1 
(AtGRP7) cDNA made by recombination with pLN2059, Sp/Smr 
pK7FWG2 derivative containing Atag39260.1 
(AtGRPS) cDNA made by recombination with pLN2061, Sp/Sm. 
pK7FWG2 derivative containing AtSg50250.1 
cDNA made by recombination with plN1999, 
SpR SmR 
pENTRD-TOPO derivative carrying hopU1 
with a FLAG coding sequence, Kim' 
pBI121 derivative containing hopU1 for HopU1 
GUS localization, Km. 
erminal FLAG fusion made by recombination 
with plN2O86, Spr/Smir 
pLN462 derivative containing hopU1 with a C 
Primer 
set used 
in cloning 
P1132, 
P1273 
P1819, 
P1820 
P1821, 
P1822 
P1889, 
P1890 
P1951, 
P1952 
P1917, 
P1918 
P1923, 
P1924 
P1895, 
P1896 
P1929, 
P1932 
P531, 
P687 
P1925, 
P1926 
P1927, 
P1928 
P605, 
P606 
Reference 
This work 
This work 
This work 
This work 
This work 
This work 
This work 
This work 
Fu, Z. Q., Guo, M. & Alfano, 
. R. Pseudomonas Syringae 
Hrp is a type III secreted 
protein that is required for 
plant pathogenesis, injection 
of effectors, and secretion 
of the HrpZ1 harpin. J. 
Bacteriol. 188, 6060-6069 
(2006) 
his work 
This work 
This work 
This work 
This work 
his work 
his work 
his work 
his work 
his work 
his work 
his work 
his work 
his work 
his work 
his work 
his work 
his work 
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Designation 
LN2256 
LN2433 
LN2593 
LN2594 
PLN2595 
PLN2596 
LN2597 
LN2689 
LN2694 
ML.123 
pPZP212 
pRK415 
0153) 
Primer 
ale 
P 605 
P606 
P687 
P688 
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TABLE 2-continued 
Bacterial strains and plasmids used in this study 
Characteristics 
SpR/SmR 
bRK415 derivative 
bGEX-SX-1 deriva 
GST, Apr 
bGEX-SX-1 deriva 
GST, Api 
bGEX-SX-1 deriva 
GST, Apr 
bGEX-SX-1 deriva 
GST, Api 
bGEX-SX-1 deriva 
GST, Apr 
bGEX-SX-1 derivat 
GST, Api 
bGEX-SX-1 deriva 
GST, Apr 
Broad-host-range c 
containing a hop 
deletion mutation, Tc, Sp. 
ive expressing A 
ive expressing A 
ive expressing A 
ive expressing A 
ive expressing A 
ive expressing At 
ive expressing A 
pK7FWG2 derivative containing Atag24770.1 
cDNA made by recombination with pLN1998, 
U1 nonpolar 
oning vector, Gm Km' 
Binary vector for transient expression, Sp/Sm. 
Binary vector for transient expression of GFP, 
Broad-host-range vector, unstable in absence of 
selection, Tc. 
TABLE 3 
Primer information 
Sequences of primer 
5'-AAGCGCCCTCAGATGAAGATATCATGCTACCCATG-3' 
5'-CATGGGTAGCATGATATCTTCATCTGAGGGCGCTT-3' 
5'-CACCCAACAACCTAATAGTAGAACAATGAATATA-3' 
5'-AATCTGACTTAATACAAATAAATGCTTTCCTT-3' 
Primer 
set used 
in cloning Reference 
P1058, 
P1059 
P1078, 
P1079 
P2332, 
P2333 
P2334, 
P2335 
P2336, 
P2337 
P2338, 
P2339 
P2340, 
P2341 
P2488, 
P2489 
P2342, 
P2343 
his work 
This work 
This work 
This work 
This work 
This work 
This work 
This work 
This work 
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28 
-continued 
&2 11s LENGTH 35 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 2 
catgggtagc atgatatott Catctgaggg cqctt 
<210> SEQ ID NO 3 
&2 11s LENGTH 34 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 3 
cacccaacaa cctaatagta gaacaatgaa tata 
<210> SEQ ID NO 4 
&2 11s LENGTH 33 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 4 
aatctgacitt aatacaaata aatgctttcc titc 
<210 SEQ ID NO 5 
&2 11s LENGTH 27 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 5 
cacaagct to go acataa.ca acggtga 
<210> SEQ ID NO 6 
&2 11s LENGTH 2.8 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 6 
atgaggatcc ggatgggCat gct cqaag 
<210 SEQ ID NO 7 
&2 11s LENGTH 2.8 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 7 
atgaaagctt agg cagttgt c gattitat 
<210 SEQ ID NO 8 
&2 11s LENGTH 30 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
35 
34 
33 
27 
28 
28 
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<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 8 
atat citagag to catgaagg aggcc.gtacg 
<210 SEQ ID NO 9 
&2 11s LENGTH 2.8 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 9 
atgaga.gcto goctotcacg acgcc act 
<210> SEQ ID NO 10 
&2 11s LENGTH 2.8 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 10 
agtact.cgag aatctgacitt aatacaaa 
<210> SEQ ID NO 11 
&2 11s LENGTH 18 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 11 
gcaaatagog g gttactic 
<210> SEQ ID NO 12 
&2 11s LENGTH 18 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 12 
gtotgg.cgca togcacat 
<210> SEQ ID NO 13 
&2 11s LENGTH 26 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 13 
cacaagcttcaacaaccitaa tagtag 
<210> SEQ ID NO 14 
&2 11s LENGTH 33 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 14 
30 
28 
28 
18 
18 
26 
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cgcggatcca aatgaatata aatcgacaac toc 
<210 SEQ ID NO 15 
&2 11s LENGTH 27 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 15 
cc.gcto gagt caaatctgac ttaatac 
<210> SEQ ID NO 16 
&2 11s LENGTH 2.8 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 16 
agtagaattic atggctgctt cagottcg 
<210 SEQ ID NO 17 
&2 11s LENGTH 2.8 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 17 
agtact.cgag to aatattgg cqc cittgg 
<210> SEQ ID NO 18 
&2 11s LENGTH 2.8 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 18 
agtaggat.cc tdatgactitc titcagtac 
<210 SEQ ID NO 19 
&2 11s LENGTH 2.8 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 19 
agtact.cgag toaacgc.citt gttcgttc 
<210> SEQ ID NO 20 
&2 11s LENGTH 30 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 20 
agtaggat.cc tdatggct to ttctatagitt 
<210> SEQ ID NO 21 
33 
27 
28 
28 
28 
28 
30 
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&2 11s LENGTH 2.8 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 21 
agtact.cgag ttaatatoca C gocttgg 
<210> SEQ ID NO 22 
&2 11s LENGTH 30 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 22 
agtc gaattic atgtctgaag titgagtaccg 
<210> SEQ ID NO 23 
&2 11s LENGTH 29 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 23 
agtcCtcgag ttaccago.cg CCaccaccg 
<210> SEQ ID NO 24 
&2 11s LENGTH 26 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 24 
caccaacaat ggcttcttct atagitt 
<210> SEQ ID NO 25 
&2 11s LENGTH 18 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 25 
atat coacgc cittggagg 
<210> SEQ ID NO 26 
&2 11s LENGTH 26 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 26 
caccaacaat gacittcttca gtacta 
<210 SEQ ID NO 27 
&2 11s LENGTH 18 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
28 
30 
29 
26 
18 
26 
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OTHER INFORMATION: Artifical sequence - Primer 
SEQUENCE: 27 
acgccttgtt cqttccitc 
<400 
SEQ ID NO 28 
LENGTH 26 
TYPE DNA 
ORGANISM: Artificial sequence 
FEATURE: 
OTHER INFORMATION: Artifical sequence - Primer 
SEQUENCE: 28 
caccaacaat gg.cgtocggit gatgtt 
<400 
SEQ ID NO 29 
LENGTH 18 
TYPE DNA 
ORGANISM: Artificial sequence 
FEATURE: 
OTHER INFORMATION: Artifical sequence - Primer 
SEQUENCE: 29 
ccatcc tocca coaccacc 
<400 
SEQ ID NO 30 
LENGTH 26 
TYPE DNA 
ORGANISM: Artificial sequence 
FEATURE: 
OTHER INFORMATION: Artifical sequence - Primer 
SEQUENCE: 30 
caccaacaat gtctgaagtt gagtac 
<400 
SEQ ID NO 31 
LENGTH 18 
TYPE DNA 
ORGANISM: Artificial sequence 
FEATURE: 
OTHER INFORMATION: Artifical sequence - Primer 
SEQUENCE: 31 
ccago.cgc.ca ccaccgcc 
<400 
SEQ ID NO 32 
LENGTH 2.8 
TYPE DNA 
ORGANISM: Artificial sequence 
FEATURE: 
OTHER INFORMATION: Artifical sequence - Primer 
SEQUENCE: 32 
agtcctcgag titaccatcct coaccacc 
<400 
SEQ ID NO 33 
LENGTH 29 
TYPE DNA 
ORGANISM: Artificial sequence 
FEATURE: 
OTHER INFORMATION: Artifical sequence - Primer 
SEQUENCE: 33 
18 
26 
18 
26 
18 
28 
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cacc gaattic atggcgtc.cg gtgatgttg 
<210> SEQ ID NO 34 
<211& LENGTH 22 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 34 
tggttcacgt agtgggcc at cq 
<210 SEQ ID NO 35 
<211& LENGTH 24 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 35 
caccatggct gottcagott cqtc 
<210 SEQ ID NO 36 
&2 11s LENGTH 2.0 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 36 
atattggcgc cittggaggcc 
<210 SEQ ID NO 37 
&2 11s LENGTH 32 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 37 
agattotaga atgaatataa atcgacaact gc 
<210 SEQ ID NO 38 
&2 11s LENGTH 35 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 38 
agatggat.cc aatctgacitt aatacaaata aatgc 
<210 SEQ ID NO 39 
&2 11s LENGTH 18 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 39 
gccagattaa gottctgg 
<210> SEQ ID NO 40 
29 
22 
24 
20 
32 
35 
18 
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&2 11s LENGTH 2.0 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 40 
to gatatoac toggagtc.cg 
<210> SEQ ID NO 41 
&2 11s LENGTH 43 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 41 
cgtocggtga t gttgagtat aaatgctt.cg ttggaggtot agc 
<210> SEQ ID NO 42 
&2 11s LENGTH 43 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 42 
gctagaccitc Caacgaag catttatactica acatcaccgg acg 
<210> SEQ ID NO 43 
<211& LENGTH: 40 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 43 
gcatgg gcca citgatgacaa agctottgag act gcctitcg 
<210> SEQ ID NO 44 
<211& LENGTH: 40 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 44 
cgaagg cagt citcaagagct ttgtcatcag togcc catgc 
<210> SEQ ID NO 45 
&2 11s LENGTH 38 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 45 
ccaagatcat taacgataaa gag actdgaa gatcaagg 
<210> SEQ ID NO 46 
&2 11s LENGTH 38 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
20 
43 
43 
40 
40 
38 
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<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 46 
ccttgatctt coagtctott tatcgittaat gatcttgg 
<210> SEQ ID NO 47 
&2 11s LENGTH 38 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 47 
cgatcgtgag actggaaaat caaggggatt cqgattog 
<210> SEQ ID NO 48 
&2 11s LENGTH 38 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 48 
cgaatcc.gaa tocccttgat tittccagtct cacgatcg 
<210 SEQ ID NO 49 
<211& LENGTH: 40 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 49 
ggacaagatc. tcgatggcaa aag catcact gttaac gagg 
<210 SEQ ID NO 50 
<211& LENGTH: 40 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 50 
ccitcgittaac agtgatgctt ttgccatcga gatcttgtc.c 
<210 SEQ ID NO 51 
&2 11s LENGTH 38 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 51 
gttaac gagg Ctcagtcaaa aggaag.cggt gg.cgg.cgg 
<210> SEQ ID NO 52 
&2 11s LENGTH 38 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 52 
38 
38 
38 
40 
40 
38 
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cc.gcc.gc.cac cqctitccttt to actgagcc togttaac 
<210 SEQ ID NO 53 
&2 11s LENGTH 25 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 53 
attgatcc.gg cccagtatica gttgt 
<210> SEQ ID NO 54 
&2 11s LENGTH 2.0 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 54 
ccagat cago: aaaacaatcc 
<210 SEQ ID NO 55 
&2 11s LENGTH 39 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 55 
cgtgag acto gaagatcaaa aggattcgga titcgtcacc 
<210 SEQ ID NO 56 
&2 11s LENGTH 39 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 56 
ggtgac gaat cogaatccitt ttgat cittcc agt citcacg 
<210 SEQ ID NO 57 
&2 11s LENGTH 25 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 57 
cgcgaattica togcgtc.cgg to atg 
<210 SEQ ID NO 58 
&2 11s LENGTH 34 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 58 
taagaatgcg gcc.gctaatc gtgactgagc citcg 
<210 SEQ ID NO 59 
38 
25 
20 
39 
39 
25 
34 
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&2 11s LENGTH 23 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 59 
gc gaatticca gtcacgagga agc 23 
<210 SEQ ID NO 60 
<211& LENGTH 22 
&212> TYPE DNA 
<213> ORGANISM: Artificial sequence 
&220s FEATURE 
<223> OTHER INFORMATION: Artifical sequence - Primer 
<400 SEQUENCE: 60 
gggatccitta coatccitcca co 22 
<210> SEQ ID NO 61 
&2 11s LENGTH 13 
&212> TYPE PRT 
<213> ORGANISM: Pseudomonas syringae 
<400 SEQUENCE: 61 
Gly Thr Pro Leu Tyr Arg Glu Val Asn. Asn Tyr Lieu Arg 
1 5 10 
<210> SEQ ID NO 62 
&2 11s LENGTH 19 
&212> TYPE PRT 
<213> ORGANISM: Pseudomonas syringae 
<400 SEQUENCE: 62 
Gly Gly Arg Tyr Val Glu Pro Ala Phe Met Ser Thr Thr Arg Ile Lys 
1 5 10 15 
Asp Ser Ala 
<210 SEQ ID NO 63 
<211& LENGTH: 14 
&212> TYPE PRT 
<213> ORGANISM: Pseudomonas syringae 
<400 SEQUENCE: 63 
Ile Ser Gly Ser Ser Glin Ala Pro Ser Glu Glu Glu Ile Met 
1 5 10 
<210> SEQ ID NO 64 
&2 11s LENGTH 13 
&212> TYPE PRT 
<213> ORGANISM: Pseudomonas syringae 
<400 SEQUENCE: 64 
Thir Ser Cys Lieu. Tyr Arg Pro Ile Asn His His Leu Arg 
1 5 10 
<210 SEQ ID NO 65 
&2 11s LENGTH 19 
&212> TYPE PRT 
<213> ORGANISM: Pseudomonas syringae 
<400 SEQUENCE: 65 
Gly Asn Thr Tyr Arg Asp Asp Ala Phe Met Ser Thr Ser Thr Arg Met 
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1 5 10 15 
Asp Val Thr 
<210 SEQ ID NO 66 
<211& LENGTH: 14 
&212> TYPE PRT 
<213> ORGANISM: Pseudomonas syringae 
<400 SEQUENCE: 66 
Ile Gly Pro Phe Ser Lys Asn Pro Tyr Glu Asp Glu Ala Lieu 
1 5 10 
<210 SEQ ID NO 67 
&2 11s LENGTH 13 
&212> TYPE PRT 
<213> ORGANISM: Pseudomonas syringae 
<400 SEQUENCE: 67 
Thir Ser Cys Lieu. Tyr Arg Pro Ile Asn His His Leu Arg 
1 5 10 
<210 SEQ ID NO 68 
&2 11s LENGTH 19 
&212> TYPE PRT 
<213> ORGANISM: Pseudomonas syringae 
<400> SEQUENCE: 68 
Gly Lys Thr Tyr Arg Asp Glu Ala Phe Met Ser Thr Ser Thr His Met 
1 5 10 15 
Glin Wal Ser 
<210 SEQ ID NO 69 
<211& LENGTH: 14 
&212> TYPE PRT 
<213> ORGANISM: Pseudomonas syringae 
<400 SEQUENCE: 69 
Ile Gly Pro Phe Ser Lys Asn Pro Tyr Glu Asp Glu Ala Lieu 
1 5 10 
<210 SEQ ID NO 70 
&2 11s LENGTH 13 
&212> TYPE PRT 
<213> ORGANISM: Pseudomonas syringae 
<400 SEQUENCE: 70 
Gly Asp Arg Lieu. Tyr Arg Ala Asp Ser Arg Pro Pro Asp 
1 5 10 
<210 SEQ ID NO 71 
&2 11s LENGTH 19 
&212> TYPE PRT 
<213> ORGANISM: Pseudomonas syringae 
<400 SEQUENCE: 71 
Gly Phe Val Arg Tyr Asp Asp Gly Tyr Val Ser Thr Ser Leu Ser Leu 
1 5 10 15 
Arg Ser Ala 
<210 SEQ ID NO 72 
Jan. 31, 2008 
US 2008/0028487 A1 Jan. 31, 2008 
39 
-continued 
<211& LENGTH: 14 
&212> TYPE PRT 
<213> ORGANISM: Pseudomonas syringae 
<400 SEQUENCE: 72 
Leu Gly Val Tyr Ser Pro His Pro Tyr Glu Gln Glu Val Ser 
1 5 10 
<210 SEQ ID NO 73 
&2 11s LENGTH 13 
&212> TYPE PRT 
<213> ORGANISM: Pseudomonas syringae 
<400 SEQUENCE: 73 
Asp Asp Llys Lieu. Tyr Arg Ala Asp Ser Arg Pro Pro Asp 
1 5 10 
<210> SEQ ID NO 74 
&2 11s LENGTH 19 
&212> TYPE PRT 
<213> ORGANISM: Pseudomonas syringae 
<400 SEQUENCE: 74 
Gly Phe Val Arg His Asp Asp Gly Tyr Val Ser Thr Ser Ile Ser Leu 
1 5 10 15 
Arg Ser Ala 
<210 SEQ ID NO 75 
<211& LENGTH: 14 
&212> TYPE PRT 
<213> ORGANISM: Pseudomonas syringae 
<400 SEQUENCE: 75 
Leu Gly Ala Tyr Ser Pro His Pro Asp Glu Gln Glu Val Ser 
1 5 10 
<210 SEQ ID NO 76 
&2 11s LENGTH 13 
&212> TYPE PRT 
<213> ORGANISM: Pseudomonas syringae 
<400 SEQUENCE: 76 
Cys Tyr Tyr Val Tyr Arg Gly Val Arg Gly Ile Arg Phe 
1 5 10 
<210 SEQ ID NO 77 
&2 11s LENGTH 19 
&212> TYPE PRT 
<213> ORGANISM: Pseudomonas syringae 
<400 SEQUENCE: 77 
Gly Lys Ser Val Tyr Phe Gly Glin Phe Thr Ser Thr Ser Leu Arg Lys 
1 5 10 15 
Glu Ala Thr 
<210 SEQ ID NO 78 
<211& LENGTH: 14 
&212> TYPE PRT 
<213> ORGANISM: Pseudomonas syringae 
<400 SEQUENCE: 78 
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Ile Lys Glin Phe Ser Phe Phe Pro Ser Glu Asp Glu Val Leu 
1 5 10 
<210 SEQ ID NO 79 
&2 11s LENGTH 13 
&212> TYPE PRT 
<213> ORGANISM: Pseudomonas syringae 
<400 SEQUENCE: 79 
Asp Met Lys Val Tyr Arg Gly Thr Asp Lieu. Asn Pro Leu 
1 5 10 
<210 SEQ ID NO 80 
&2 11s LENGTH 19 
&212> TYPE PRT 
<213> ORGANISM: Pseudomonas syringae 
<400 SEQUENCE: 80 
Gly Lys Thr Phe Lys Asp Asp Gly Phe Met Ser Thr Ala Lieu Val Lys 
1 5 10 15 
Glu Ser Ser 
<210> SEQ ID NO 81 
<211& LENGTH: 14 
&212> TYPE PRT 
<213> ORGANISM: Pseudomonas syringae 
<400> SEQUENCE: 81 
Val Ser Lys Ile Ser Tyr Phe Pro Asp Glu Ala Glu Lieu Lieu 
1 5 10 
<210> SEQ ID NO 82 
&2 11s LENGTH 13 
&212> TYPE PRT 
<213> ORGANISM: Pseudomonas syringae 
<400 SEQUENCE: 82 
His Arg Val Val Tyr Arg Gly Lieu Lys Lieu. Asp Pro Lys 
1 5 10 
<210 SEQ ID NO 83 
&2 11s LENGTH 19 
&212> TYPE PRT 
<213> ORGANISM: Pseudomonas syringae 
<400 SEQUENCE: 83 
Gly Asn. Ile Ile Ile Asp Lys Ala Phe Met Ser Thr Ser Pro Asp Lys 
1 5 10 15 
Ala Trp Ile 
<210> SEQ ID NO 84 
<211& LENGTH: 14 
&212> TYPE PRT 
<213> ORGANISM: Pseudomonas syringae 
<400 SEQUENCE: 84 
Leu Gly Asp Val Ala His Phe Lys Gly Glu Ala Glu Met Lieu 
1 5 10 
<210 SEQ ID NO 85 
&2 11s LENGTH 13 
&212> TYPE PRT 
US 2008/0028487 A1 
<213> ORGANISM: Pseudomonas 
Asn Ile Thr Val Tyr Arg Trp 
1 
<400 
Asn. Thir Ile Lys Glu Asp Lys 
1 
SEQUENCE: 
SEQ ID NO 
LENGTH 19 
TYPE PRT 
ORGANISM: Pseudomonas 
SEQUENCE: 
Glu Arg Lieu 
<400 
Leu Ser Ala Ile Gly Gly Phe 
1 
<400 
Val Val Lys Thr Phe Arg Gly 
1 
<400 
Gly Lys Val Gly His Asp Asp 
1 
SEQ ID NO 
LENGTH 14 
TYPE PRT 
ORGANISM: Pseudomonas 
SEQUENCE: 
SEQ ID NO 
LENGTH 13 
TYPE PRT 
ORGANISM: Pseudomonas 
SEQUENCE: 
SEQ ID NO 
LENGTH 19 
TYPE PRT 
ORGANISM: Pseudomonas 
SEQUENCE: 
Gly Val Ala 
Val Ser Gly Ile Ser Asn Tyr 
Val Val Lys Thr Phe Arg Gly 
SEQ ID NO 
LENGTH 14 
TYPE PRT 
ORGANISM: Pseudomonas 
SEQUENCE: 
SEQ ID NO 
LENGTH 13 
TYPE PRT 
ORGANISM: Pseudomonas 
SEQUENCE: 
85 
5 
86 
86 
5 
87 
87 
5 
88 
88 
5 
89 
89 
5 
9 O 
9 O 
5 
91 
91 
5 
41 
-continued 
syringae 
Cys Gly Met Pro Glu Phe 
10 
syringae 
Gly Tyr Met Ser Thr Ser Leu Ser Ser 
10 15 
syringae 
Ala Ser Glu Lys Glu Ile Leu 
10 
syringae 
Thr Arg Gly Gly Asp Ala 
10 
syringae 
Gly Tyr Leu Ser Thr Ser Leu Asn Pro 
10 15 
syringae 
Lys Asn. Glu Lys Glu Ile Leu 
10 
syringae 
Thr Glin Gly Arg Asp Ala 
10 
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42 
Jan. 31, 2008 
-continued 
SEQ ID NO 92 
LENGTH 19 
TYPE PRT 
ORGANISM: Pseudomonas syringae 
<400 SEQUENCE: 92 
Gly Glin Val Gly His Asp Ala Gly Tyr Lieu Ser Thr Ser Arg 
1 5 10 
Gly Val Ala 
SEQ ID NO 93 
LENGTH 14 
TYPE PRT 
ORGANISM: Pseudomonas syringae 
<400 SEQUENCE: 93 
Val Ser Glu Ile Ser Ile Glu Gly Asp Glu Glin Glu Ile Leu 
1 5 10 
What is claimed is: 
1. A method of enhancing an innate immune response of 
a plant comprising: 
over-expressing in the planta HopU1 Substrate capable of 
being ADP-ribosylated by HopU1. 
2. The method of claim 1, further comprising introducing 
into a plant cell a construct comprising a polynucleotide 
encoding the HopU1 substrate, wherein the HopU1 substrate 
polynucleotide is operably linked to a promoter functional in 
plant cells to yield transformed plant cells; and 
regenerating a transgenic plant from the transformed plant 
cells, wherein the HopU1 substrate is expressed in the 
cells of the transgenic plant at levels sufficient to 
enhance the immune response in the transgenic plant. 
3. The method of claim 1, wherein the HopU1 substrates 
are RNA binding proteins. 
4. The method of claim 3, wherein the HopU1 substrates 
comprise Glycine rich RNA binding proteins or Chloroplast 
RNA binding proteins. 
5. The method of claim 1, wherein the HopU1 substrates 
are mutated in their ADP-ribosylation sites. 
6. The method of claim 1, the biotic stresses comprise a 
pathogen, bacteria, fungi, protozoa a virus, an insect, 
wounding, or physical damage caused by people. 
7. The method of claim 1, wherein the plant undergoes a 
hypersensitive response and cells in contact with the biotic 
stress die. 
8. The method of claim 1, further comprising identifying 
a substrate of HopU1 and introducing the substrate into the 
plant cell. 
9. The method of claim 8, further comprising identifying 
one or more HopU1 Substrates by incubating a candidate 
Asp Pro 
15 
substrate of HopU1 in the presence of HopU1 and assaying 
the substrate to determine if the substrate underwent ADP 
ribosylation. 
10. The method of claim 1, wherein the plant is a 
dicotyledonous plant. 
11. The method of claim 1, wherein the plant is a 
monocotyledonous plant. 
12. The method of claim 1, wherein the plant is corn, 
tomato, soybean, Sunflower, Sorghum, canola, wheat, alfalfa, 
cotton, rice, barley or millet. 
13. The method of claim 1, wherein immune response is 
enhanced as compared to a control plant, wherein the 
HopU1 substrate is not over-expressed in the control plant. 
14. A method of identifying a substrate of HopU1 in a 
plant or animal cell comprising: 
incubating an extract from a plant or animal cell Suspected 
of comprising a candidate HopU1 Substrate in the 
presence of HopU1 and assaying the Substrate to deter 
mine if the candidate HopU1 substrate underwent 
ADP-ribosylation. 
15. The method of claim 14, wherein the candidate 
HopU1 substrate is a RNA binding protein. 
16. The method of claim 15, wherein the RNA binding 
protein is a glycine rich RNA binding protein. 
17. The method of claim 14, wherein HopU1 ribosylates 
the candidate HopU1 substrate in the presence of NAD". 
18. The method of claim 14, wherein the assaying further 
comprises separating the extract on a SDS-PAGE gel and 
using autoradiography to determine a molecular mass of the 
candidate HopU1 substrate. 
k k k k k 
